CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 17beta-estradiol 3-benzoate
Accession: CHEBI:77006
browse the term
Definition: A benzoate ester resulting from the formal condensation of benzoic acid with the phenolic hydroxy group of 17beta-estradiol.
Synonyms: exact_synonym: (17beta)-17-hydroxyestra-1(10),2,4-trien-3-yl benzoate
related_synonym: 17-beta-Estradiol 3-benzoate; 17beta-estradiol monobenzoate; Agofollin Depot; Benovocylin; Benzo-Gynoestryl; Benztrone; Estrogin; Folone; Formula=C25H28O3; InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1; InChIKey=UYIFTLBWAOGQBI-BZDYCCQFSA-N; Mesalin; Ovahormon; Ovasterol-B; Primogyn B; Progynon B; Progynon benzoate; SMILES=C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)c5ccccc5)ccc34)[C@@H]1CC[C@@H]2O; benzoate d'estradiol; benzoato de estradiol; beta-estradiol 3-benzoate; estra-1,3,5(10)-triene-3,17beta-diol 3-benzoate; estradiol benzoate; estradiol monobenzoate; estradioli benzoas; oestradiol 3-benzoate; oestradiol benzoate; oestradiol monobenzoate
xref: CAS:50-50-0; DrugBank:DB00783; Drug_Central:1058; KEGG:C13444; KEGG:D01953; LINCS:LSM-26352
xref_mesh: MESH:C074283
xref: PMID:18356042; PMID:19090709; Reaxys:3107526; Wikipedia:Estradiol_benzoate
G
A2m
alpha-2-macroglobulin
increases methylation multiple interactions
EXP
estradiol 3-benzoate results in increased methylation of A2M promoter [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of A2M mRNA
CTD
PMID:27415467 PMID:32741896
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Aadacl3
arylacetamide deacetylase-like 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of AADACL3 mRNA
CTD
PMID:32741896
NCBI chr 5:156,242,182...156,252,215
Ensembl chr 5:156,243,415...156,252,205
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression increases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of ABCB1A mRNA estradiol 3-benzoate results in increased expression of ABCB1A mRNA fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of ABCB1A mRNA]
CTD
PMID:23707492
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of ABCB1B mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCB1B mRNA; Fulvestrant inhibits the reaction [estradiol 3-benzoate results in decreased expression of ABCB1B mRNA]
CTD
PMID:23707492 PMID:32741896
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc1
ATP binding cassette subfamily C member 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of ABCC1 protein
CTD
PMID:23707492
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of ABCC2 promoter
CTD
PMID:27415467
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc4
ATP binding cassette subfamily C member 4
decreases expression increases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of ABCC4 protein estradiol 3-benzoate results in increased expression of ABCC4 mRNA; estradiol 3-benzoate results in increased expression of ABCC4 protein fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of ABCC4 mRNA]
CTD
PMID:23707492
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcc5
ATP binding cassette subfamily C member 5
affects expression increases expression multiple interactions
EXP
estradiol 3-benzoate affects the expression of ABCC5 protein estradiol 3-benzoate results in increased expression of ABCC5 mRNA; estradiol 3-benzoate results in increased expression of ABCC5 protein [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCC5 mRNA
CTD
PMID:23707492 PMID:32741896
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Abcc8
ATP binding cassette subfamily C member 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCC8 mRNA
CTD
PMID:32741896
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
G
Abcc9
ATP binding cassette subfamily C member 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCC9 mRNA
CTD
PMID:32741896
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
G
Abcg2
ATP binding cassette subfamily G member 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of ABCG2 mRNA; estradiol 3-benzoate results in decreased expression of ABCG2 protein
CTD
PMID:23707492
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg3l3
ATP-binding cassette, subfamily G (WHITE), member 3-like 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABCG3L3 mRNA
CTD
PMID:32741896
NCBI chr14:4,844,161...4,892,194
Ensembl chr14:4,844,218...4,892,194
G
Abi3bp
ABI family member 3 binding protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABI3BP mRNA
CTD
PMID:32741896
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA
CTD
PMID:32741896
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
G
Ace2
angiotensin converting enzyme 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ACE2 mRNA
CTD
PMID:32741896
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acod1
aconitate decarboxylase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACOD1 mRNA
CTD
PMID:32741896
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
G
Acot1
acyl-CoA thioesterase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ACOT1 mRNA
CTD
PMID:32741896
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acrbp
acrosin binding protein
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of ACRBP promoter
CTD
PMID:27415467
NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213
G
Acsl4
acyl-CoA synthetase long-chain family member 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ACSL4 mRNA
CTD
PMID:32741896
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
estradiol 3-benzoate promotes the reaction [Thioacetamide results in increased expression of ACTA2 mRNA]
CTD
PMID:15716488
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Actb
actin, beta
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RASA4 mRNA
CTD
PMID:32741896
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Acvr2b
activin A receptor type 2B
decreases expression affects expression
ISO EXP
estradiol 3-benzoate results in decreased expression of ACVR2B mRNA estradiol 3-benzoate affects the expression of SCGB2A2 mRNA
CTD
PMID:14994273 PMID:15925091
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Adal
adenosine deaminase-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ADAL mRNA
CTD
PMID:32741896
NCBI chr 3:108,101,857...108,119,557
Ensembl chr 3:108,101,857...108,118,516 Ensembl chr 3:108,101,857...108,118,516
G
Adamts12
ADAM metallopeptidase with thrombospondin type 1 motif, 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS12 mRNA
CTD
PMID:32741896
NCBI chr 2:60,032,873...60,327,629
Ensembl chr 2:60,032,873...60,327,629
G
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS14 mRNA
CTD
PMID:32741896
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
G
Adamts15
ADAM metallopeptidase with thrombospondin type 1 motif, 15
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS15 mRNA
CTD
PMID:32741896
NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249
G
Adamts2
ADAM metallopeptidase with thrombospondin type 1 motif, 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS2 mRNA
CTD
PMID:32741896
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS4 mRNA
CTD
PMID:32741896
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS5 mRNA
CTD
PMID:32741896
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
G
Adamts6
ADAM metallopeptidase with thrombospondin type 1 motif, 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS6 mRNA
CTD
PMID:32741896
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
G
Adap2
ArfGAP with dual PH domains 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAP2 mRNA
CTD
PMID:32741896
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Adar
adenosine deaminase, RNA-specific
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAR mRNA
CTD
PMID:32741896
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
G
Adcy4
adenylate cyclase 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADCY4 mRNA
CTD
PMID:32741896
NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108
G
Adcy7
adenylate cyclase 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADCY7 mRNA
CTD
PMID:32741896
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Adgrb2
adhesion G protein-coupled receptor B2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of ADGRB2 promoter
CTD
PMID:27415467
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
G
Adgre1
adhesion G protein-coupled receptor E1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRE1 mRNA
CTD
PMID:32741896
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
G
Adgre4
adhesion G protein-coupled receptor E4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRE4 mRNA
CTD
PMID:32741896
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
G
Adgrg5
adhesion G protein-coupled receptor G5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA
CTD
PMID:32741896
NCBI chr19:10,074,787...10,098,640
Ensembl chr19:10,079,375...10,097,214
G
Adgrg7
adhesion G protein-coupled receptor G7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG7 mRNA
CTD
PMID:32741896
NCBI chr11:43,808,101...43,877,539
Ensembl chr11:43,813,801...43,876,316
G
Adm2
adrenomedullin 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of ADM2 mRNA
CTD
PMID:32741896
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
G
Ado
2-aminoethanethiol dioxygenase
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of ADO promoter
CTD
PMID:27415467
NCBI chr20:21,044,815...21,045,983
Ensembl chr20:21,044,555...21,049,235
G
Agap2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AGAP2 mRNA
CTD
PMID:32741896
NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295
G
Aif1
allograft inflammatory factor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AIF1 mRNA
CTD
PMID:32741896
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aim2
absent in melanoma 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AIM2 mRNA
CTD
PMID:32741896
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:85,866,284...85,906,975
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ALDH1A3 mRNA
CTD
PMID:32741896
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ALDH4A1 mRNA
CTD
PMID:32741896
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
G
Aldob
aldolase, fructose-bisphosphate B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ALDOB mRNA
CTD
PMID:32741896
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ALOX5 mRNA
CTD
PMID:32741896
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ALOX5AP mRNA
CTD
PMID:32741896
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Amz1
archaelysin family metallopeptidase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AMZ1 mRNA
CTD
PMID:32741896
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
G
Angptl1
angiopoietin-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ANGPTL1 mRNA
CTD
PMID:32741896
NCBI chr13:68,963,186...68,981,649
Ensembl chr13:68,962,991...68,992,570
G
Ankk1
ankyrin repeat and kinase domain containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA
CTD
PMID:32741896
NCBI chr 8:49,779,862...49,788,024
Ensembl chr 8:49,779,862...49,788,024
G
Ankrd66
ankyrin repeat domain 66
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKRD66 mRNA
CTD
PMID:32741896
NCBI chr 9:17,421,432...17,441,212
Ensembl chr 9:17,411,983...17,442,647
G
Anxa13
annexin A13
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANXA13 mRNA
CTD
PMID:32741896
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
G
Aoah
acyloxyacyl hydrolase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AOAH mRNA
CTD
PMID:32741896
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
G
Ap1m2
adaptor related protein complex 1 subunit mu 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of AP1M2 promoter
CTD
PMID:27415467
NCBI chr 8:19,838,579...19,856,560
Ensembl chr 8:19,838,580...19,856,482
G
Ap1s2
adaptor related protein complex 1 subunit sigma 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AP1S2 mRNA
CTD
PMID:32741896
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
G
Apba2
amyloid beta precursor protein binding family A member 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of APBA2 mRNA
CTD
PMID:32741896
NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699
G
Apobec1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOBEC1 mRNA
CTD
PMID:32741896
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
G
Apobr
apolipoprotein B receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOBR mRNA
CTD
PMID:32741896
NCBI chr 1:181,169,019...181,173,206
Ensembl chr 1:181,168,916...181,173,528
G
Apoc3
apolipoprotein C3
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of APOC3 mRNA
CTD
PMID:32741896
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Apod
apolipoprotein D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOD mRNA
CTD
PMID:32741896
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
Apol7b
apolipoprotein L7b
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOL7B mRNA
CTD
PMID:32741896
NCBI chr 7:109,118,559...109,149,798
Ensembl chr 7:109,131,064...109,147,649
G
Apol7b-ps1
apolipoprotein L7b, pseudogene 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOL3-PS1 mRNA
CTD
PMID:32741896
NCBI chr 7:109,156,746...109,175,642
G
Apol9a
apolipoprotein L9a
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOL9A mRNA
CTD
PMID:32741896
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
G
Aqp2
aquaporin 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of AQP2 mRNA
CTD
PMID:32741896
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
G
Aqp3
aquaporin 3 (Gill blood group)
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AQP3 mRNA
CTD
PMID:32741896
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Ar
androgen receptor
multiple interactions affects expression
EXP
Flutamide inhibits the reaction [estradiol 3-benzoate results in increased expression of AR mRNA] estradiol 3-benzoate affects the expression of AR mRNA
CTD
PMID:15925091
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arf6
ADP-ribosylation factor 6
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of ARF6 promoter
CTD
PMID:27415467
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
G
Arhgap15
Rho GTPase activating protein 15
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP15 mRNA
CTD
PMID:32741896
NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:27,989,633...28,600,265
G
Arhgap4
Rho GTPase activating protein 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP4 mRNA
CTD
PMID:32741896
NCBI chr X:151,636,071...151,651,528
Ensembl chr X:151,632,454...151,651,128
G
Arhgap9
Rho GTPase activating protein 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA
CTD
PMID:32741896
NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524
G
Arhgef2
Rho/Rac guanine nucleotide exchange factor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA
CTD
PMID:32741896
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
G
Arl5c
ADP-ribosylation factor like GTPase 5C
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARL5C mRNA
CTD
PMID:32741896
NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002
G
Arnt2
aryl hydrocarbon receptor nuclear translocator 2
increases expression
EXP
estradiol 3-benzoate results in increased expression of ARNT2 mRNA; estradiol 3-benzoate results in increased expression of ARNT2 protein
CTD
PMID:12859947
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153
G
As3mt
arsenite methyltransferase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of AS3MT mRNA
CTD
PMID:32741896
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
G
Asl
argininosuccinate lyase
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of ASL promoter
CTD
PMID:27415467
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
G
Aspg
asparaginase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ASPG mRNA
CTD
PMID:32741896
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
G
Ass1
argininosuccinate synthase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ASS1 mRNA
CTD
PMID:32741896
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ATP12A mRNA
CTD
PMID:32741896
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
G
Atp13a5
ATPase 13A5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ATP13A5 mRNA
CTD
PMID:32741896
NCBI chr11:71,376,388...71,515,789
Ensembl chr11:71,376,422...71,515,789
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
EXP
estradiol 3-benzoate results in increased expression of and results in increased activity of ATP1A1 protein
CTD
PMID:22759964
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp8a2
ATPase phospholipid transporting 8A2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ATP8A2 mRNA
CTD
PMID:32741896
NCBI chr15:33,817,309...34,350,193
Ensembl chr15:33,819,755...34,350,223
G
Atp8b4
ATPase phospholipid transporting 8B4 (putative)
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ATP8B4 mRNA
CTD
PMID:32741896
NCBI chr 3:113,554,979...113,757,635
Ensembl chr 3:113,556,192...113,757,225
G
B430306N03Rikl
RIKEN cDNA B430306N03 gene
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of B430306N03RIKL mRNA
CTD
PMID:32741896
NCBI chr 9:12,681,290...12,690,555
Ensembl chr 9:12,681,535...12,690,629
G
Baalc
BAALC binder of MAP3K1 and KLF4
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of BAALC promoter
CTD
PMID:27415467
NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288
G
Bard1
BRCA1 associated RING domain 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BARD1 mRNA
CTD
PMID:32741896
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Batf
basic leucine zipper ATF-like transcription factor
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of BATF promoter
CTD
PMID:27415467
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
G
Batf3
basic leucine zipper ATF-like transcription factor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BATF3 mRNA
CTD
PMID:32741896
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of BAX mRNA; estradiol 3-benzoate results in increased expression of BAX protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BAX mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BAX protein]
CTD
PMID:24316378
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression
EXP
Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein] estradiol 3-benzoate results in increased expression of BCL2 mRNA; estradiol 3-benzoate results in increased expression of BCL2 protein
CTD
PMID:24316378
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
affects expression
EXP
estradiol 3-benzoate affects the expression of BCL2L1 mRNA
CTD
PMID:15664431
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl3
BCL3, transcription coactivator
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BCL3 mRNA
CTD
PMID:32741896
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
G
Bdnf
brain-derived neurotrophic factor
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of BDNF mRNA
CTD
PMID:21277884
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Best4
bestrophin 4
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of BEST4 mRNA
CTD
PMID:32741896
NCBI chr 5:130,622,194...130,629,045
Ensembl chr 5:130,623,438...130,627,099
G
Bex4
brain expressed, X-linked 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of BEX4 mRNA
CTD
PMID:32741896
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
G
Bhlhe22
basic helix-loop-helix family, member e22
increases expression
EXP
estradiol 3-benzoate results in increased expression of BHLHE22 mRNA
CTD
PMID:32741896
NCBI chr 2:100,486,400...100,489,510
Ensembl chr 2:100,486,400...100,489,510
G
Bid
BH3 interacting domain death agonist
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of BID protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BID protein]
CTD
PMID:24316378
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BIRC3 mRNA
CTD
PMID:32741896
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Bmerb1
bMERB domain containing 1
increases expression
EXP
estradiol 3-benzoate results in increased expression of BMERB1 mRNA
CTD
PMID:32741896
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
G
Bmp7
bone morphogenetic protein 7
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of BMP7 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of BMP7 mRNA
CTD
PMID:32741896
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
G
Bmper
BMP-binding endothelial regulator
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BMPER mRNA
CTD
PMID:32741896
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
G
Brinp3
BMP/retinoic acid inducible neural specific 3
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of BRINP3 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BRINP3 mRNA
CTD
PMID:32741896
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
G
Bst1
bone marrow stromal cell antigen 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BST1 mRNA
CTD
PMID:32741896
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
G
Btbd3
BTB domain containing 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of BTBD3 promoter
CTD
PMID:27415467
NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038
G
Btg4
BTG anti-proliferation factor 4
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of BTG4 mRNA
CTD
PMID:32741896
NCBI chr 8:51,410,774...51,425,802
Ensembl chr 8:51,422,061...51,425,796
G
Btk
Bruton tyrosine kinase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTK mRNA
CTD
PMID:32741896
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
G
Btla
B and T lymphocyte associated
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTLA mRNA
CTD
PMID:32741896
NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181
G
Btn2a2
butyrophilin, subfamily 2, member A2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of BTN2A2 mRNA
CTD
PMID:32741896
NCBI chr17:41,620,807...41,632,621
Ensembl chr17:41,620,839...41,632,618
G
Btnl9
butyrophilin-like 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BTNL9 mRNA
CTD
PMID:32741896
NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BUB1B mRNA
CTD
PMID:32741896
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
C1qa
complement C1q A chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QA mRNA
CTD
PMID:32741896
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QB mRNA
CTD
PMID:32741896
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C1qc
complement C1q C chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QC mRNA
CTD
PMID:32741896
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
G
C1r
complement C1r
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1R mRNA
CTD
PMID:32741896
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C1s
complement C1s
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1S mRNA
CTD
PMID:32741896
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
C1s-ps1
complement C1s, pseudogene 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1S-PS1 mRNA
CTD
PMID:32741896
NCBI chr 4:157,059,237...157,061,211
G
C2
complement C2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C2 mRNA
CTD
PMID:32741896
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
C3
complement C3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C3 mRNA
CTD
PMID:32741896
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C3ar1
complement C3a receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C3AR1 mRNA
CTD
PMID:32741896
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
C4a
complement C4A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C4A mRNA
CTD
PMID:32741896
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
G
C4b
complement C4B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C4B mRNA
CTD
PMID:32741896
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
C5ar2
complement C5a receptor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C5AR2 mRNA
CTD
PMID:32741896
NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517
G
C6
complement C6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C6 mRNA
CTD
PMID:32741896
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
C7
complement C7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C7 mRNA
CTD
PMID:32741896
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
G
Cabp4
calcium binding protein 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CABP4 mRNA
CTD
PMID:32741896
NCBI chr 1:201,428,671...201,442,950
Ensembl chr 1:201,428,672...201,433,172
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CACNB2 promoter
CTD
PMID:27415467
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
G
Cacng6
calcium voltage-gated channel auxiliary subunit gamma 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CACNG6 mRNA
CTD
PMID:32741896
NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341
G
Cacybp
calcyclin binding protein
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CACYBP promoter
CTD
PMID:27415467
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
G
Calhm6
calcium homeostasis modulator family member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM26F mRNA
CTD
PMID:32741896
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
G
Camp
cathelicidin antimicrobial peptide
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CAMP mRNA
CTD
PMID:32741896
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
G
Capn8
calpain 8
increases expression
EXP
estradiol 3-benzoate results in increased expression of CAPN8 mRNA
CTD
PMID:32741896
NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146
G
Capns2
calpain, small subunit 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CAPNS2 promoter
CTD
PMID:27415467
NCBI chr19:14,104,334...14,105,276
G
Car4
carbonic anhydrase 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CAR4 mRNA
CTD
PMID:32741896
NCBI chr10:69,827,945...69,836,501
Ensembl chr10:69,827,945...69,836,501
G
Card11
caspase recruitment domain family, member 11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CARD11 mRNA
CTD
PMID:32741896
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Card14
caspase recruitment domain family, member 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CARD14 mRNA
CTD
PMID:32741896
NCBI chr10:104,572,059...104,601,606
Ensembl chr10:104,566,424...104,601,905
G
Casp1
caspase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CASP1 mRNA
CTD
PMID:32741896
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CASP12 mRNA
CTD
PMID:32741896
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
multiple interactions
EXP
estradiol 3-benzoate results in increased expression of and results in increased activity of CASP3 protein; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP3 protein]
CTD
PMID:24316378
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of CASP8 mRNA estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP8 mRNA]
CTD
PMID:24316378
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases expression
EXP
estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP9 mRNA]
CTD
PMID:24316378
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cass4
Cas scaffold protein family member 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CASS4 mRNA
CTD
PMID:32741896
NCBI chr 3:161,162,520...161,202,523
Ensembl chr 3:161,163,436...161,202,186
G
Cat
catalase
multiple interactions decreases expression
EXP
Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased expression of CAT protein]
CTD
PMID:24316378
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccdc162
coiled-coil domain containing 162
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CCDC162 mRNA
CTD
PMID:32741896
NCBI chr20:45,044,891...45,237,905
Ensembl chr20:45,032,752...45,236,193
G
Ccdc170
coiled-coil domain containing 170
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCDC170 mRNA
CTD
PMID:32741896
NCBI chr 1:40,945,607...41,050,010
Ensembl chr 1:40,945,961...41,085,040
G
Ccdc80
coiled-coil domain containing 80
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCDC80 mRNA
CTD
PMID:32741896
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
G
Ccdc82
coiled-coil domain containing 82
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCDC82 mRNA
CTD
PMID:32741896
NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963
G
Ccl11
C-C motif chemokine ligand 11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL11 mRNA
CTD
PMID:32741896
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl12
C-C motif chemokine ligand 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL12 mRNA
CTD
PMID:32741896
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
G
Ccl19
C-C motif chemokine ligand 19
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL19 mRNA
CTD
PMID:32741896
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL2 mRNA
CTD
PMID:32741896
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl28
C-C motif chemokine ligand 28
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL28 mRNA estradiol 3-benzoate results in increased expression of CCL28 mRNA
CTD
PMID:32741896
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL3 mRNA
CTD
PMID:32741896
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL4 mRNA
CTD
PMID:32741896
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA
CTD
PMID:32741896
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL7 mRNA
CTD
PMID:32741896
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccl9
C-C motif chemokine ligand 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL6 mRNA
CTD
PMID:32741896
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccn2
cellular communication network factor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCN2 mRNA
CTD
PMID:32741896
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccn5
cellular communication network factor 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of WISP2 mRNA
CTD
PMID:32741896
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
G
Ccna2
cyclin A2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCNA2 mRNA
CTD
PMID:32741896
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCNB1 mRNA
CTD
PMID:32741896
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCNB2 mRNA
CTD
PMID:32741896
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccr10
C-C motif chemokine receptor 10
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CCR10 promoter
CTD
PMID:27415467
NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
G
Ccr3
C-C motif chemokine receptor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR3 mRNA
CTD
PMID:32741896
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR5 mRNA
CTD
PMID:32741896
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Ccr6
C-C motif chemokine receptor 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR6 mRNA
CTD
PMID:32741896
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Ccrl2
C-C motif chemokine receptor like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCRL2 mRNA
CTD
PMID:32741896
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
G
Cd163
CD163 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD163 mRNA
CTD
PMID:32741896
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
G
Cd177
CD177 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD177 mRNA
CTD
PMID:32741896
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
G
Cd19
CD19 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD19 mRNA
CTD
PMID:32741896
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
G
Cd200r1
CD200 receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD200R1 mRNA
CTD
PMID:32741896
NCBI chr11:55,886,937...55,921,217
Ensembl chr11:55,887,717...55,921,285
G
Cd22
CD22 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD22 mRNA
CTD
PMID:32741896
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
G
Cd226
CD226 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD226 mRNA
CTD
PMID:32741896
NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
G
Cd274
CD274 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD274 mRNA
CTD
PMID:32741896
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd300a
Cd300a molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300A mRNA
CTD
PMID:32741896
NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674
G
Cd300c2
CD300C molecule 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300C2 mRNA
CTD
PMID:32741896
NCBI chr10:100,253,312...100,258,553
Ensembl chr10:100,253,624...100,258,323
G
Cd300ld
Cd300 molecule-like family member D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LD mRNA
CTD
PMID:32741896
NCBI chr10:100,082,957...100,115,853
Ensembl chr10:100,083,490...100,115,821
G
Cd300le
Cd300 molecule-like family member E
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LE mRNA
CTD
PMID:32741896
NCBI chr10:100,271,076...100,280,400
Ensembl chr10:100,271,036...100,280,299
G
Cd300lf
Cd300 molecule-like family member F
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD300LF mRNA
CTD
PMID:32741896
NCBI chr10:100,359,942...100,376,130
Ensembl chr10:100,359,943...100,376,041
G
Cd36
CD36 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD36 mRNA
CTD
PMID:32741896
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd3e
CD3 epsilon subunit of T-cell receptor complex
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD3E mRNA
CTD
PMID:32741896
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
G
Cd4
Cd4 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD4 mRNA
CTD
PMID:32741896
NCBI chr 4:157,668,878...157,695,366
G
Cd48
Cd48 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD48 mRNA
CTD
PMID:32741896
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd5
Cd5 molecule
increases expression
EXP
estradiol 3-benzoate results in increased expression of CD5 mRNA
CTD
PMID:32741896
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
G
Cd52
CD52 molecule
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CD52 promoter
CTD
PMID:27415467
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
G
Cd53
Cd53 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD53 mRNA
CTD
PMID:32741896
NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657
G
Cd5l
Cd5 molecule-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD5L mRNA
CTD
PMID:32741896
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
G
Cd68
Cd68 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD68 mRNA
CTD
PMID:32741896
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd72
Cd72 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD72 mRNA
CTD
PMID:32741896
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
G
Cd74
CD74 molecule
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD74 mRNA
CTD
PMID:32741896
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cdca3
cell division cycle associated 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDCA3 mRNA
CTD
PMID:32741896
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdh15
cadherin 15
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CDH15 mRNA
CTD
PMID:32741896
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
G
Cdh7
cadherin 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CDH7 mRNA
CTD
PMID:32741896
NCBI chr13:26,672,058...26,821,571
Ensembl chr13:26,672,484...26,819,846
G
Cdkl4
cyclin-dependent kinase-like 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CDKL4 mRNA
CTD
PMID:32741896
NCBI chr 6:14,449,822...14,492,568
Ensembl chr 6:14,450,681...14,492,046
G
Cds1
CDP-diacylglycerol synthase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CDS1 mRNA
CTD
PMID:32741896
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
G
Ceacam19
CEA cell adhesion molecule 19
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CEACAM19 mRNA
CTD
PMID:32741896
NCBI chr 1:79,542,107...79,550,927
Ensembl chr 1:79,542,107...79,550,927
G
Cebpe
CCAAT/enhancer binding protein epsilon
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CEBPE mRNA
CTD
PMID:32741896
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
G
Celf2
CUGBP, Elav-like family member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CELF2 mRNA
CTD
PMID:32741896
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
G
Celf4
CUGBP, Elav-like family member 4
increases expression
EXP
estradiol 3-benzoate results in increased expression of CELF4 mRNA
CTD
PMID:32741896
NCBI chr18:16,786,578...17,065,045
Ensembl chr18:16,786,867...17,064,786
G
Celsr1
cadherin, EGF LAG seven-pass G-type receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CELSR1 mRNA
CTD
PMID:32741896
NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164
G
Cenpa
centromere protein A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPA mRNA
CTD
PMID:32741896
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpf
centromere protein F
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPF mRNA
CTD
PMID:32741896
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpt
centromere protein T
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPT mRNA
CTD
PMID:32741896
NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142
G
Cenpw
centromere protein W
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CENPW mRNA
CTD
PMID:32741896
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
G
Cfap210
cilia and flagella associated protein 210
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CFAP210 mRNA
CTD
PMID:32741896
NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607
G
Cfb
complement factor B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CFB mRNA
CTD
PMID:32741896
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfi
complement factor I
increases methylation multiple interactions
EXP
estradiol 3-benzoate results in increased methylation of CFI promoter [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CFI mRNA
CTD
PMID:27415467 PMID:32741896
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Cfp
complement factor properdin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CFP mRNA
CTD
PMID:32741896
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
G
Cga
glycoprotein hormones, alpha polypeptide
decreases expression
ISO
estradiol 3-benzoate results in decreased expression of CGA mRNA
CTD
PMID:15223135
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
G
Chad
chondroadherin
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CHAD promoter
CTD
PMID:27415467
NCBI chr10:79,512,170...79,515,941
Ensembl chr10:79,511,931...79,515,940
G
Chgb
chromogranin B
increases expression
EXP
estradiol 3-benzoate results in increased expression of CHGB mRNA
CTD
PMID:32741896
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
G
Chi3l1
chitinase 3 like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHI3L1 mRNA
CTD
PMID:32741896
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Chmp4bl1
chromatin modifying protein 4B-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CHMP4BL1 mRNA
CTD
PMID:32741896
NCBI chr 4:68,049,742...68,050,791
Ensembl chr 4:68,049,705...68,050,676
G
Chp2
calcineurin-like EF hand protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHP2 mRNA
CTD
PMID:32741896
NCBI chr 1:176,757,945...176,772,443
Ensembl chr 1:176,757,876...176,772,139
G
Chrd
chordin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHRD mRNA
CTD
PMID:32741896
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
increases expression
EXP
estradiol 3-benzoate results in increased expression of CHRNA3 mRNA
CTD
PMID:32741896
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CHRNB4 mRNA
CTD
PMID:32741896
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
G
Chst14
carbohydrate sulfotransferase 14
decreases methylation increases expression
EXP
estradiol 3-benzoate results in decreased methylation of CHST14 promoter estradiol 3-benzoate results in increased expression of CHST14 mRNA
CTD
PMID:27415467
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
G
Ciita
class II, major histocompatibility complex, transactivator
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CIITA mRNA
CTD
PMID:32741896
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Ckap2
cytoskeleton associated protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA
CTD
PMID:32741896
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Ckap2l
cytoskeleton associated protein 2-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2L mRNA
CTD
PMID:32741896
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
G
Ckmt1
creatine kinase, mitochondrial 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKMT1 mRNA
CTD
PMID:32741896
NCBI chr 3:108,329,859...108,335,760
Ensembl chr 3:108,330,705...108,335,758
G
Clca1
chloride channel accessory 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA
CTD
PMID:32741896
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
G
Clca2
chloride channel accessory 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA
CTD
PMID:32741896
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
G
Clca4l
chloride channel calcium activated 4-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA4L mRNA
CTD
PMID:32741896
NCBI chr 2:233,826,133...233,846,137
Ensembl chr 2:233,826,133...233,846,716
G
Clca5
chloride channel accessory 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA5 mRNA
CTD
PMID:32741896
NCBI chr 2:233,796,569...233,818,867
Ensembl chr 2:233,796,575...233,818,949
G
Clcnkb
chloride voltage-gated channel Kb
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CLCNKB mRNA
CTD
PMID:32741896
NCBI chr 5:153,710,086...153,733,162
Ensembl chr 5:153,710,094...153,732,153
G
Cldn10
claudin 10
increases expression
EXP
estradiol 3-benzoate results in increased expression of CLDN10 mRNA
CTD
PMID:32741896
NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526
G
Clec10a
C-type lectin domain containing 10A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC10A mRNA
CTD
PMID:32741896
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
G
Clec12a
C-type lectin domain family 12, member A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC12A mRNA
CTD
PMID:32741896
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
G
Clec4a1
C-type lectin domain family 4, member A1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4A1 mRNA
CTD
PMID:32741896
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
G
Clec4a3
C-type lectin domain family 4, member A3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4A mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4A3 mRNA
CTD
PMID:32741896
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
G
Clec4d
C-type lectin domain family 4, member D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4D mRNA
CTD
PMID:32741896
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
G
Clec4e
C-type lectin domain family 4, member E
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC4E mRNA
CTD
PMID:32741896
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
G
Clec7a
C-type lectin domain containing 7A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC7A mRNA
CTD
PMID:32741896
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Clec9a
C-type lectin domain containing 9A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLEC9A mRNA
CTD
PMID:32741896
NCBI chr 4:162,859,742...162,875,742
Ensembl chr 4:162,860,308...162,875,352
G
Clspn
claspin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLSPN mRNA
CTD
PMID:32741896
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Cltrn
collectrin, amino acid transport regulator
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CLTRN promoter
CTD
PMID:27415467
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
G
Clu
clusterin
affects expression
EXP
estradiol 3-benzoate affects the expression of CLU mRNA
CTD
PMID:15925091
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Clxn
calaxin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLXN mRNA
CTD
PMID:32741896
NCBI chr11:85,977,231...85,996,561
Ensembl chr11:85,983,304...85,996,538
G
Cmbl
carboxymethylenebutenolidase homolog
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CMBL mRNA
CTD
PMID:32741896
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmklr1
chemerin chemokine-like receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CMKLR1 mRNA
CTD
PMID:32741896
NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129
G
Cmpk2
cytidine/uridine monophosphate kinase 2
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of CMPK2 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CMPK2 mRNA
CTD
PMID:32741896
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
G
Cmtm3
CKLF-like MARVEL transmembrane domain containing 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CMTM3 mRNA
CTD
PMID:32741896
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
G
Cndp1
carnosine dipeptidase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CNDP1 mRNA
CTD
PMID:32741896
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
G
Cnga1
cyclic nucleotide gated channel subunit alpha 1
increases expression
EXP
estradiol 3-benzoate results in increased expression of CNGA1 protein
CTD
PMID:22759964
NCBI chr14:35,566,947...35,605,065
Ensembl chr14:35,567,125...35,605,065
G
Cnn2
calponin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CNN2 mRNA
CTD
PMID:32741896
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
G
Cnr2
cannabinoid receptor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CNR2 mRNA
CTD
PMID:32741896
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Cntnap1
contactin associated protein 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CNTNAP1 promoter
CTD
PMID:27415467
NCBI chr10:86,109,850...86,125,612
Ensembl chr10:86,111,643...86,125,611
G
Coasy
Coenzyme A synthase
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of COASY promoter
CTD
PMID:27415467
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
G
Col15a1
collagen type XV alpha 1 chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL15A1 mRNA
CTD
PMID:32741896
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
G
Col3a1
collagen type III alpha 1 chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL3A1 mRNA
CTD
PMID:32741896
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col5a1
collagen type V alpha 1 chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL5A1 mRNA
CTD
PMID:32741896
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Col6a2
collagen type VI alpha 2 chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA
CTD
PMID:32741896
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Colec12
collectin sub-family member 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COLEC12 mRNA
CTD
PMID:32741896
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
G
Corin
corin, serine peptidase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CORIN mRNA
CTD
PMID:32741896
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
G
Cpeb3
cytoplasmic polyadenylation element binding protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CPEB3 mRNA
CTD
PMID:32741896
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
G
Cpne7
copine 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CPNE7 mRNA
CTD
PMID:32741896
NCBI chr19:51,164,316...51,182,676
Ensembl chr19:51,166,034...51,182,677
G
Cpz
carboxypeptidase Z
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CPZ mRNA
CTD
PMID:32741896
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
G
Creb3l4
cAMP responsive element binding protein 3-like 4
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of CREB3L4 promoter
CTD
PMID:27415467
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
G
Creb5
cAMP responsive element binding protein 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CREB5 mRNA
CTD
PMID:32741896
NCBI chr 4:82,393,091...82,794,320
Ensembl chr 4:82,393,730...82,790,325
G
Crh
corticotropin releasing hormone
increases expression
EXP
estradiol 3-benzoate results in increased expression of CRH mRNA
CTD
PMID:32741896
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crmp1
collapsin response mediator protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRMP1 mRNA
CTD
PMID:32741896
NCBI chr14:73,509,933...73,556,192
Ensembl chr14:73,509,933...73,556,177
G
Crym
crystallin, mu
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CRYM mRNA
CTD
PMID:32741896
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
G
Csf1r
colony stimulating factor 1 receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSF1R mRNA
CTD
PMID:32741896
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf3r
colony stimulating factor 3 receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSF3R mRNA
CTD
PMID:32741896
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Csgalnact1
chondroitin sulfate N-acetylgalactosaminyltransferase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSGALNACT1 mRNA
CTD
PMID:32741896
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
G
Cst7
cystatin F
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CST7 mRNA
CTD
PMID:32741896
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
G
Csta
cystatin A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSTA mRNA
CTD
PMID:32741896
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
G
Cth
cystathionine gamma-lyase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CTH mRNA
CTD
PMID:32741896
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctrc
chymotrypsin C
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CTRC mRNA
CTD
PMID:32741896
NCBI chr 5:154,147,314...154,156,540
Ensembl chr 5:154,147,316...154,156,528
G
Ctss
cathepsin S
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CTSS mRNA
CTD
PMID:32741896
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Ctsw
cathepsin W
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CTSW mRNA
CTD
PMID:32741896
NCBI chr 1:202,772,395...202,777,021
Ensembl chr 1:202,772,572...202,775,964
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL1 mRNA
CTD
PMID:32741896
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl13
C-X-C motif chemokine ligand 13
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL13 mRNA
CTD
PMID:32741896
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL2 mRNA
CTD
PMID:32741896
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL3 mRNA
CTD
PMID:32741896
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl9
C-X-C motif chemokine ligand 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL9 mRNA
CTD
PMID:32741896
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr2
C-X-C motif chemokine receptor 2
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of CXCR2 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCR2 mRNA
CTD
PMID:32741896
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCR4 mRNA
CTD
PMID:32741896
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cxcr6
C-X-C motif chemokine receptor 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCR6 mRNA
CTD
PMID:32741896
NCBI chr 8:123,434,417...123,439,568
Ensembl chr 8:123,416,325...123,439,526
G
Cyba
cytochrome b-245 alpha chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBA mRNA
CTD
PMID:32741896
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYBB mRNA
CTD
PMID:32741896
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cygb
cytoglobin
multiple interactions
EXP
estradiol 3-benzoate promotes the reaction [Thioacetamide results in increased expression of CYGB mRNA]
CTD
PMID:15716488
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of CYP17A1 protein
CTD
PMID:24752506
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
affects response to substance
ISO
CYP19A1 protein affects the susceptibility to estradiol 3-benzoate
CTD
PMID:16884724
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of CYP1B1 protein [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP1B1 mRNA
CTD
PMID:24752506 PMID:32741896
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA
CTD
PMID:32741896
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of CYP2A1 protein
CTD
PMID:24752506
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
G
Cyp2c13
cytochrome P450, family 2, subfamily c, polypeptide 13
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP2C13 mRNA
CTD
PMID:32741896
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
G
Cyp2c22
cytochrome P450, family 2, subfamily c, polypeptide 22
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of CYP2C22 mRNA
CTD
PMID:32741896
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYP3A9 mRNA
CTD
PMID:32741896
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyth4
cytohesin 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CYTH4 mRNA
CTD
PMID:32741896
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
G
Dcaf12l1
DDB1 and CUL4 associated factor 12-like 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of DCAF12L1 mRNA
CTD
PMID:32741896
NCBI chr X:123,695,286...123,698,905
Ensembl chr X:123,695,286...123,698,905
G
Dclk1
doublecortin-like kinase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DCLK1 mRNA
CTD
PMID:32741896
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Ddah2
DDAH family member 2, ADMA-independent
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of DDAH2 promoter
CTD
PMID:27415467
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
G
Ddx60
DEXD/H-box helicase 60
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DDX60 mRNA
CTD
PMID:32741896
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Defa5
defensin alpha 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEFA5 mRNA
CTD
PMID:32741896
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
G
Degs2
delta(4)-desaturase, sphingolipid 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of DEGS2 mRNA
CTD
PMID:32741896
NCBI chr 6:127,596,063...127,613,293
Ensembl chr 6:127,596,071...127,613,293
G
Depdc1
DEP domain containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1 mRNA
CTD
PMID:32741896
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
G
Depdc1b
DEP domain containing 1B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA
CTD
PMID:32741896
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
G
Derl3
derlin 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of DERL3 mRNA
CTD
PMID:32741896
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
G
Deup1
deuterosome assembly protein 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of DEUP1 promoter
CTD
PMID:27415467
NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199
G
Dhrs2
dehydrogenase/reductase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of DHRS2 mRNA
CTD
PMID:32741896
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
G
Dhx58
DEXH-box helicase 58
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DHX58 mRNA
CTD
PMID:32741896
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
G
Diaph3
diaphanous-related formin 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DIAPH3 mRNA
CTD
PMID:32741896
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
G
Dlx4
distal-less homeobox 4
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of DLX4 promoter
CTD
PMID:27415467
NCBI chr10:80,085,037...80,090,434
Ensembl chr10:80,085,465...80,090,456
G
Dmbt1
deleted in malignant brain tumors 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DMBT1 mRNA
CTD
PMID:32741896
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
G
Dnase2b
deoxyribonuclease 2 beta
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of DNASE2B promoter
CTD
PMID:27415467
NCBI chr 2:235,470,915...235,515,211
Ensembl chr 2:235,470,919...235,486,295
G
Dnttip1
deoxynucleotidyltransferase, terminal, interacting protein 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of DNTTIP1 promoter
CTD
PMID:27415467
NCBI chr 3:153,481,718...153,505,403
Ensembl chr 3:153,481,705...153,505,759
G
Dock11
dedicator of cytokinesis 11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK11 mRNA
CTD
PMID:32741896
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
G
Dock2
dedicator of cytokinesis 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK2 mRNA
CTD
PMID:32741896
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
G
Dock4
dedicator of cytokinesis 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK4 mRNA
CTD
PMID:32741896
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
G
Dok2
docking protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOK2 mRNA
CTD
PMID:32741896
NCBI chr15:45,826,984...45,841,409
Ensembl chr15:45,827,398...45,841,402
G
Dok3
docking protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOK3 mRNA
CTD
PMID:32741896
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
G
Dpep2
dipeptidase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA
CTD
PMID:32741896
NCBI chr19:33,883,557...33,896,487
Ensembl chr19:33,885,478...33,891,954
G
Dpp4
dipeptidylpeptidase 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPP4 mRNA
CTD
PMID:32741896
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Drd2
dopamine receptor D2
multiple interactions
EXP
estradiol 3-benzoate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]
CTD
PMID:10936494
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dsc1
desmocollin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of DSC1 mRNA
CTD
PMID:32741896
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
G
Dsc2
desmocollin 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of DSC2 promoter
CTD
PMID:27415467
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
G
Dsc3
desmocollin 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of DSC3 promoter
CTD
PMID:27415467
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Dtx4
deltex E3 ubiquitin ligase 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DTX4 mRNA
CTD
PMID:32741896
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
G
Duox1
dual oxidase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOX1 mRNA
CTD
PMID:32741896
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duox2
dual oxidase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOX2 mRNA
CTD
PMID:32741896
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Duoxa1
dual oxidase maturation factor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOXA1 mRNA
CTD
PMID:32741896
NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:109,249,923...109,260,499
G
Duoxa2
dual oxidase maturation factor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUOXA2 mRNA
CTD
PMID:32741896
NCBI chr 3:109,245,337...109,249,055
Ensembl chr 3:109,245,476...109,248,968
G
Dusp18
dual specificity phosphatase 18
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DUSP18 mRNA
CTD
PMID:32741896
NCBI chr14:78,790,183...78,811,576
Ensembl chr14:78,787,505...78,811,576
G
E2f7
E2F transcription factor 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F7 mRNA
CTD
PMID:32741896
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
E2f8
E2F transcription factor 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F8 mRNA
CTD
PMID:32741896
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Ebf1
EBF transcription factor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF1 mRNA
CTD
PMID:32741896
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
G
Ebf3
EBF transcription factor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBF3 mRNA
CTD
PMID:32741896
NCBI chr 1:191,996,726...192,114,593
Ensembl chr 1:191,996,730...192,114,359
G
Ebi3
Epstein-Barr virus induced 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EBI3 mRNA
CTD
PMID:32741896
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
G
Ect2
epithelial cell transforming 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ECT2 mRNA
CTD
PMID:32741896
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Efcab12
EF-hand calcium binding domain 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of EFCAB12 mRNA
CTD
PMID:32741896
NCBI chr 4:148,869,381...148,892,922
Ensembl chr 4:148,869,387...148,890,560
G
Efnb2
ephrin B2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EFNB2 mRNA
CTD
PMID:32741896
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
G
Egf
epidermal growth factor
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of EGF mRNA
CTD
PMID:32741896
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
increases expression
EXP
estradiol 3-benzoate results in increased expression of EGFR protein
CTD
PMID:15778002
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr2
early growth response 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EGR2 mRNA
CTD
PMID:32741896
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of EHHADH mRNA
CTD
PMID:32741896
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Eif4e3
eukaryotic translation initiation factor 4E family member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EIF4E3 mRNA
CTD
PMID:32741896
NCBI chr 4:132,258,502...132,301,808
Ensembl chr 4:132,258,502...132,301,808
G
Elapor2
endosome-lysosome associated apoptosis and autophagy regulator family member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELAPOR2 mRNA
CTD
PMID:32741896
NCBI chr 4:24,613,163...24,805,729
Ensembl chr 4:24,613,163...24,805,729
G
Elavl2
ELAV like RNA binding protein 2
increases expression
EXP
estradiol 3-benzoate results in increased expression of ELAVL2 mRNA
CTD
PMID:32741896
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
G
Elf5
E74 like ETS transcription factor 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA
CTD
PMID:32741896
NCBI chr 3:89,808,837...89,836,977
Ensembl chr 3:89,797,880...89,836,973
G
Elmod1
ELMO domain containing 1
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of ELMOD1 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELMOD1 mRNA
CTD
PMID:32741896
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
G
Entpd3
ectonucleoside triphosphate diphosphohydrolase 3
increases expression
EXP
estradiol 3-benzoate results in increased expression of ENTPD3 mRNA
CTD
PMID:32741896
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
G
Entpd8
ectonucleoside triphosphate diphosphohydrolase 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ENTPD8 mRNA
CTD
PMID:32741896
NCBI chr 3:7,885,277...7,895,517
Ensembl chr 3:7,889,909...7,895,296
G
Eomes
eomesodermin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EOMES mRNA
CTD
PMID:32741896
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
G
Epha5
EPH receptor A5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EPHA5 mRNA
CTD
PMID:32741896
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of EPHX1 protein
CTD
PMID:24752506
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epsti1
epithelial stromal interaction 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EPSTI1 mRNA
CTD
PMID:32741896
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
G
Erich5
glutamate-rich 5
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of ERICH5 mRNA
CTD
PMID:32741896
NCBI chr 7:65,655,829...65,682,221
Ensembl chr 7:65,657,204...65,680,207
G
Erp27
endoplasmic reticulum protein 27
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ERP27 mRNA
CTD
PMID:32741896
NCBI chr 4:169,804,656...169,821,660
Ensembl chr 4:169,804,658...169,821,660
G
Esr1
estrogen receptor 1
affects binding affects expression increases methylation decreases expression increases expression multiple interactions
ISO EXP
estradiol 3-benzoate binds to ESR1 protein estradiol 3-benzoate affects the expression of ESR1 mRNA estradiol 3-benzoate results in increased methylation of ESR1 exon; estradiol 3-benzoate results in increased methylation of ESR1 intron estradiol 3-benzoate results in decreased expression of ESR1; estradiol 3-benzoate results in decreased expression of ESR1 protein estradiol 3-benzoate results in increased expression of ESR1 mRNA; estradiol 3-benzoate results in increased expression of ESR1 protein methyl palmitate inhibits the reaction [estradiol 3-benzoate results in increased expression of ESR1 protein]
CTD
PMID:11162928 PMID:15375486 PMID:15716488 PMID:15778002 PMID:15925091 PMID:19350480 PMID:22016562 PMID:27830003 PMID:32967526 More...
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
affects expression decreases expression increases expression
EXP
estradiol 3-benzoate affects the expression of ESR2 mRNA estradiol 3-benzoate results in decreased expression of ESR2; estradiol 3-benzoate results in decreased expression of ESR2 mRNA estradiol 3-benzoate results in increased expression of ESR2 mRNA
CTD
PMID:15375486 PMID:19350480 PMID:24352099 PMID:27830003
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Evi2a
ecotropic viral integration site 2A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2A mRNA
CTD
PMID:32741896
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
G
Evi2b
ecotropic viral integration site 2B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2B mRNA
CTD
PMID:32741896
NCBI chr10:64,472,693...64,474,311
Ensembl chr10:64,471,505...64,481,560
G
Exoc3l4
exocyst complex component 3-like 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EXOC3L4 mRNA
CTD
PMID:32741896
NCBI chr 6:130,452,680...130,466,684
Ensembl chr 6:130,452,661...130,466,683
G
F10
coagulation factor X
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of F10 mRNA
CTD
PMID:32741896
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F11r
F11 receptor
multiple interactions increases expression
ISO
fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of F11R mRNA]; fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of F11R protein] estradiol 3-benzoate results in increased expression of F11R mRNA; estradiol 3-benzoate results in increased expression of F11R protein
CTD
PMID:19433574
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
Faim2
Fas apoptotic inhibitory molecule 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of FAIM2 promoter
CTD
PMID:27415467
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
G
Fam163b
family with sequence similarity 163, member B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM163B mRNA
CTD
PMID:32741896
NCBI chr 3:10,437,383...10,466,458
Ensembl chr 3:10,437,383...10,466,458
G
Fam171b
family with sequence similarity 171, member B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA
CTD
PMID:32741896
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
G
Fam229b
family with sequence similarity 229, member B
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of FAM229B promoter
CTD
PMID:27415467
NCBI chr20:42,538,853...42,552,355
Ensembl chr20:42,538,868...42,552,248
G
Fam3b
FAM3 metabolism regulating signaling molecule B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM3B mRNA
CTD
PMID:32741896
NCBI chr11:36,831,532...36,863,902
Ensembl chr11:36,831,532...36,869,713
G
Fam83d
family with sequence similarity 83, member D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FAM83D mRNA
CTD
PMID:32741896
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fam89a
family with sequence similarity 89, member A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM89A mRNA
CTD
PMID:32741896
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
G
Fas
Fas cell surface death receptor
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of FAS mRNA; estradiol 3-benzoate results in increased expression of FAS protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FAS mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FAS protein]
CTD
PMID:24316378
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of FASLG mRNA; estradiol 3-benzoate results in increased expression of FASLG protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG protein]
CTD
PMID:24316378
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbln1
fibulin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA
CTD
PMID:32741896
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbxo16
F-box protein 16
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA
CTD
PMID:32741896
NCBI chr15:39,492,268...39,541,493
Ensembl chr15:39,492,377...39,541,480
G
Fbxo6
F-box protein 6
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of FBXO6 promoter
CTD
PMID:27415467
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
G
Fcer1g
Fc epsilon receptor Ig
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER1G mRNA
CTD
PMID:32741896
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
G
Fcer2
Fc epsilon receptor II
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER2 mRNA
CTD
PMID:32741896
NCBI chr12:1,742,809...1,754,476
Ensembl chr12:1,742,815...1,754,476
G
Fcgbpl1
Fc fragment of IgG binding protein-like 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of FCGBPL1 mRNA
CTD
PMID:32741896
NCBI chr 1:83,424,788...83,462,802
Ensembl chr 1:83,424,788...83,462,799
G
Fcgr1a
Fc gamma receptor 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR1A mRNA
CTD
PMID:32741896
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fcgr2a
Fc gamma receptor 2A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2A mRNA
CTD
PMID:32741896
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2B mRNA
CTD
PMID:32741896
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fcnb
ficolin B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCNB mRNA
CTD
PMID:32741896
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
G
Fcrl2
Fc receptor-like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCRL2 mRNA
CTD
PMID:32741896
NCBI chr 2:172,694,308...172,707,261
Ensembl chr 2:172,694,308...172,707,051
G
Fcrl5
Fc receptor-like 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCRL5 mRNA
CTD
PMID:32741896
NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:172,881,448...172,913,148
G
Fermt3
FERM domain containing kindlin 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FERMT3 mRNA
CTD
PMID:32741896
NCBI chr 1:204,189,483...204,207,683
Ensembl chr 1:204,189,484...204,207,587
G
Ffar4
free fatty acid receptor 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FFAR4 mRNA
CTD
PMID:32741896
NCBI chr 1:235,873,576...235,891,597
Ensembl chr 1:235,873,576...235,891,597
G
Fgd2
FYVE, RhoGEF and PH domain containing 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FGD2 mRNA
CTD
PMID:32741896
NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
G
Fgg
fibrinogen gamma chain
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FGG mRNA
CTD
PMID:32741896
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Flrt2
fibronectin leucine rich transmembrane protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLRT2 mRNA
CTD
PMID:32741896
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
G
Flt3
Fms related receptor tyrosine kinase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FLT3 mRNA
CTD
PMID:32741896
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fn1
fibronectin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FN1 mRNA
CTD
PMID:32741896
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fndc1
fibronectin type III domain containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FNDC1 mRNA
CTD
PMID:32741896
NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:47,281,844...47,364,259
G
Fndc5
fibronectin type III domain containing 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FNDC5 mRNA
CTD
PMID:32741896
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
G
Fndc9
fibronectin type III domain containing 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FNDC9 mRNA
CTD
PMID:32741896
NCBI chr10:30,664,435...30,668,213
Ensembl chr10:30,667,091...30,667,771
G
Folr2
folate receptor beta
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOLR2 mRNA
CTD
PMID:32741896
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions
EXP ISO
estradiol 3-benzoate results in decreased expression of FOS protein [estradiol 3-benzoate co-treated with Progesterone] results in increased abundance of FOS protein
CTD
PMID:21190954 PMID:22577852
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOSL2 mRNA
CTD
PMID:32741896
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxq1
forkhead box Q1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FOXQ1 mRNA
CTD
PMID:32741896
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Fsbp
fibrinogen silencer binding protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FSBP mRNA
CTD
PMID:32741896
NCBI chr 5:25,058,003...25,064,276
Ensembl chr 5:25,032,066...25,104,616
G
Fscn1
fascin actin-bundling protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FSCN1 mRNA
CTD
PMID:32741896
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Fshb
follicle stimulating hormone subunit beta
decreases expression multiple interactions decreases secretion
ISO EXP
estradiol 3-benzoate results in decreased expression of FSHB mRNA Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased secretion of FSHB protein]
CTD
PMID:15223135 PMID:24316378
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Fxyd3
FXYD domain-containing ion transport regulator 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FXYD3 mRNA
CTD
PMID:32741896
NCBI chr 1:86,305,531...86,312,455
G
Fyb1
FYN binding protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FYB1 mRNA
CTD
PMID:32741896
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FYN mRNA
CTD
PMID:32741896
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
G0s2
G0/G1switch 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of G0S2 mRNA
CTD
PMID:32741896
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
increases expression
EXP
estradiol 3-benzoate results in increased expression of GABBR1 mRNA
CTD
PMID:21277884
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GABRA1 mRNA
CTD
PMID:32741896
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabra4
gamma-aminobutyric acid type A receptor subunit alpha 4
multiple interactions
EXP
[Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of GABRA4 mRNA
CTD
PMID:19394921
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
G
Galnt13
polypeptide N-acetylgalactosaminyltransferase 13
increases expression
EXP
estradiol 3-benzoate results in increased expression of GALNT13 mRNA
CTD
PMID:32741896
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
G
Galnt14
polypeptide N-acetylgalactosaminyltransferase 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GALNT14 mRNA
CTD
PMID:32741896
NCBI chr 6:21,756,039...21,977,533
Ensembl chr 6:21,755,195...21,972,192
G
Galr3
galanin receptor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GALR3 mRNA
CTD
PMID:32741896
NCBI chr 7:110,603,525...110,608,429
Ensembl chr 7:110,605,226...110,607,685
G
Gas7
growth arrest specific 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GAS7 mRNA
CTD
PMID:32741896
NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276
G
Gask1a
golgi associated kinase 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM198A mRNA
CTD
PMID:32741896
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
G
Gbp1
guanylate binding protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP1 mRNA
CTD
PMID:32741896
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp4
guanylate binding protein 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP4 mRNA
CTD
PMID:32741896
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gbp6
guanylate binding protein family member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP6 mRNA
CTD
PMID:32741896
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gch1
GTP cyclohydrolase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GCH1 mRNA
CTD
PMID:32741896
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GCNT1 mRNA
CTD
PMID:32741896
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
G
Gcsam
germinal center-associated, signaling and motility
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GCSAM mRNA
CTD
PMID:32741896
NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992
G
Gda
guanine deaminase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GDA mRNA
CTD
PMID:32741896
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gfi1
growth factor independent 1 transcriptional repressor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GFI1 mRNA
CTD
PMID:32741896
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
G
Gimap6
GTPase, IMAP family member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP6 mRNA
CTD
PMID:32741896
NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:77,652,610...77,659,116
G
Gimap7
GTPase, IMAP family member 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GIMAP7 mRNA
CTD
PMID:32741896
NCBI chr 4:77,670,522...77,674,692
Ensembl chr 4:77,670,367...77,675,272
G
Gjb2
gap junction protein, beta 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GJB2 mRNA
CTD
PMID:32741896
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gjb6
gap junction protein, beta 6
increases expression
EXP
estradiol 3-benzoate results in increased expression of GJB6 mRNA
CTD
PMID:32741896
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
G
Gk5
glycerol kinase 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GK5 mRNA
CTD
PMID:32741896
NCBI chr 8:96,682,469...96,751,407
Ensembl chr 8:96,682,470...96,749,166
G
Glb1l3
galactosidase, beta 1-like 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLB1L3 mRNA
CTD
PMID:32741896
NCBI chr 8:25,179,165...25,220,904
Ensembl chr 8:25,179,165...25,220,904
G
Gli2
GLI family zinc finger 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLI2 mRNA
CTD
PMID:32741896
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
G
Glipr1
GLI pathogenesis-related 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLIPR1 mRNA
CTD
PMID:32741896
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glrx
glutaredoxin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLRX mRNA
CTD
PMID:32741896
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glt1d1
glycosyltransferase 1 domain containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GLT1D1 mRNA
CTD
PMID:32741896
NCBI chr12:28,975,984...29,049,707
Ensembl chr12:28,975,988...29,049,695
G
Gmfg
glia maturation factor, gamma
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GMFG mRNA
CTD
PMID:32741896
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
G
Gna15
G protein subunit alpha 15
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GNA15 mRNA
CTD
PMID:32741896
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
G
Gnat2
G protein subunit alpha transducin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GNAT2 mRNA
CTD
PMID:32741896
NCBI chr 2:195,726,371...195,735,866
Ensembl chr 2:195,726,762...195,735,866
G
Gngt2
G protein subunit gamma transducin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GNGT2 mRNA
CTD
PMID:32741896
NCBI chr10:80,776,003...80,784,235
G
Gnrh1
gonadotropin releasing hormone 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with GNRH1 protein] results in increased secretion of LH protein
CTD
PMID:19574278
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
G
Gnrhr
gonadotropin releasing hormone receptor
decreases expression
ISO
estradiol 3-benzoate results in decreased expression of GNRHR mRNA
CTD
PMID:15223135
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
G
Gp2
glycoprotein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GP2 mRNA
CTD
PMID:32741896
NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619
G
Gp6
glycoprotein VI
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GP6 mRNA
CTD
PMID:32741896
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
G
Gpat3
glycerol-3-phosphate acyltransferase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPAT3 mRNA
CTD
PMID:32741896
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpc5
glypican 5
multiple interactions decreases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GPC5 mRNA estradiol 3-benzoate results in decreased expression of GPC5 mRNA
CTD
PMID:32741896
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
G
Gpr176
G protein-coupled receptor 176
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR176 mRNA
CTD
PMID:32741896
NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226
G
Gpr31
G protein-coupled receptor 31
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA
CTD
PMID:32741896
NCBI chr 1:52,926,953...52,927,912
G
Gpr34
G protein-coupled receptor 34
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR34 mRNA
CTD
PMID:32741896
NCBI chr X:9,104,829...9,113,796
Ensembl chr X:9,104,565...9,148,601
G
Gpr35
G protein-coupled receptor 35
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR35 mRNA
CTD
PMID:32741896
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
G
Gpr68
G protein-coupled receptor 68
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR68 mRNA
CTD
PMID:32741896
NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
G
Gpr84
G protein-coupled receptor 84
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR84 mRNA
CTD
PMID:32741896
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
G
Gpr87
G protein-coupled receptor 87
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR87 mRNA
CTD
PMID:32741896
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
G
Gprc5a
G protein-coupled receptor, class C, group 5, member A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPRC5A mRNA
CTD
PMID:32741896
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
G
Gpx1
glutathione peroxidase 1
multiple interactions decreases expression
EXP
Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased expression of GPX1 mRNA]
CTD
PMID:24316378
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA
CTD
PMID:32741896
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx7
glutathione peroxidase 7
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of GPX7 promoter
CTD
PMID:27415467
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
G
Grap
GRB2-related adaptor protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GRAP mRNA
CTD
PMID:32741896
NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056
G
Greb1
growth regulating estrogen receptor binding 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GREB1 mRNA
CTD
PMID:32741896
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
increases phosphorylation multiple interactions
EXP
estradiol 3-benzoate results in increased phosphorylation of GRIN1 protein fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN1 protein]; U 0126 inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN1 protein]
CTD
PMID:21763338
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
increases expression decreases expression multiple interactions increases phosphorylation
EXP
estradiol 3-benzoate results in increased expression of GRIN2B mRNA estradiol 3-benzoate results in decreased expression of GRIN2B mRNA fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN2B protein]; U 0126 inhibits the reaction [estradiol 3-benzoate results in increased phosphorylation of GRIN2B protein]
CTD
PMID:21190954 PMID:21277884 PMID:21763338
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
EXP
estradiol 3-benzoate results in increased expression of GRIN2C mRNA
CTD
PMID:21277884
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grk3
G protein-coupled receptor kinase 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of GRK3 promoter
CTD
PMID:27415467
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
G
Grn
granulin precursor
increases expression
EXP
estradiol 3-benzoate results in increased expression of GRN mRNA
CTD
PMID:11137762
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsap
gamma-secretase activating protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSAP mRNA
CTD
PMID:32741896
NCBI chr 4:13,813,046...13,907,875
Ensembl chr 4:13,813,046...13,907,814
G
Gsc
goosecoid homeobox
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSC mRNA
CTD
PMID:32741896
NCBI chr 6:123,388,072...123,390,111
Ensembl chr 6:123,388,072...123,390,111
G
Gsta3l1
glutathione S-transferase alpha 3 like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of GSTA3L1 mRNA
CTD
PMID:32741896
NCBI chr 9:23,619,691...23,628,517
Ensembl chr 9:23,620,010...23,632,333
G
Gucy2c
guanylate cyclase 2C
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of GUCY2C promoter
CTD
PMID:27415467
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
G
Gxylt2
glucoside xylosyltransferase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GXYLT2 mRNA
CTD
PMID:32741896
NCBI chr 4:133,347,230...133,449,708
Ensembl chr 4:133,347,499...133,449,454
G
Gzmb
granzyme B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMB mRNA
CTD
PMID:32741896
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Gzmm
granzyme M
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMM mRNA
CTD
PMID:32741896
NCBI chr 7:10,011,065...10,016,841
Ensembl chr 7:10,011,066...10,016,665
G
Habp2
hyaluronan binding protein 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of HABP2 promoter
CTD
PMID:27415467
NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:255,315,915...255,350,160
G
Havcr1
hepatitis A virus cellular receptor 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of HAVCR1 mRNA
CTD
PMID:32741896
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCK mRNA
CTD
PMID:32741896
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Hcst
hematopoietic cell signal transducer
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCST mRNA
CTD
PMID:32741896
NCBI chr 1:85,676,976...85,679,083
Ensembl chr 1:85,676,979...85,679,012
G
Hdac9
histone deacetylase 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HDAC9 mRNA
CTD
PMID:32741896
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
G
Helz2
helicase with zinc finger 2
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HELZ2 mRNA estradiol 3-benzoate results in increased expression of HELZ2 mRNA
CTD
PMID:32741896
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
G
Herc6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HERC6 mRNA
CTD
PMID:32741896
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
G
Heyl
hes-related family bHLH transcription factor with YRPW motif-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA
CTD
PMID:32741896
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152
G
Hip1
huntingtin interacting protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HIP1 mRNA
CTD
PMID:32741896
NCBI chr12:21,133,364...21,267,796
Ensembl chr12:21,133,406...21,267,725
G
Hk3
hexokinase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HK3 mRNA
CTD
PMID:32741896
NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HMOX1 mRNA
CTD
PMID:32741896
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hoxc5
homeo box C5
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of HOXC5 promoter
CTD
PMID:27415467
NCBI chr 7:134,150,988...134,154,410
Ensembl chr 7:134,150,988...134,154,410
G
Hrob
homologous recombination factor with OB-fold
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HROB mRNA
CTD
PMID:32741896
NCBI chr10:87,206,017...87,222,483
Ensembl chr10:87,206,049...87,222,483
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSD11B2 mRNA
CTD
PMID:32741896
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hsh2d
hematopoietic SH2 domain containing
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSH2D mRNA
CTD
PMID:32741896
NCBI chr16:17,630,519...17,649,932
Ensembl chr16:17,635,322...17,647,991
G
Hspa2
heat shock protein family A (Hsp70) member 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of HSPA2 promoter
CTD
PMID:27415467
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with Progesterone] results in increased expression of HSPA8 mRNA; Progesterone promotes the reaction [estradiol 3-benzoate results in increased expression of HSPA8 mRNA]
CTD
PMID:9990085
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions increases expression
EXP
Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A mRNA]; Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A protein] estradiol 3-benzoate results in increased expression of HTR2A mRNA; estradiol 3-benzoate results in increased expression of HTR2A protein
CTD
PMID:17398000
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of HTR2C mRNA
CTD
PMID:32741896
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Hvcn1
hydrogen voltage-gated channel 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HVCN1 mRNA
CTD
PMID:32741896
NCBI chr12:34,341,673...34,370,010
Ensembl chr12:34,335,190...34,370,141
G
Hyal3
hyaluronidase 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of HYAL3 promoter
CTD
PMID:27415467
NCBI chr 8:108,254,385...108,260,020
Ensembl chr 8:108,250,667...108,260,647
G
Icam2
intercellular adhesion molecule 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM2 mRNA
CTD
PMID:32741896
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
G
Icam5
intercellular adhesion molecule 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA
CTD
PMID:32741896
NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
G
Icos
inducible T-cell co-stimulator
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICOS mRNA
CTD
PMID:32741896
NCBI chr 9:62,368,075...62,406,900
Ensembl chr 9:62,383,832...62,405,672
G
Ier5
immediate early response 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IER5 mRNA
CTD
PMID:32741896
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
G
Ifi44
interferon-induced protein 44
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFI44 mRNA
CTD
PMID:32741896
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFI44L mRNA
CTD
PMID:32741896
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifit1bl
interferon-induced protein with tetratricopeptide repeats 1B-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT1BL mRNA
CTD
PMID:32741896
NCBI chr 1:232,122,618...232,167,317
Ensembl chr 1:232,122,562...232,167,518
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFIT3 mRNA
CTD
PMID:32741896
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm1
interferon induced transmembrane protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IFITM1 mRNA
CTD
PMID:32741896
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Igf1
insulin-like growth factor 1
affects expression decreases expression
EXP
estradiol 3-benzoate affects the expression of IGF1 mRNA estradiol 3-benzoate results in decreased expression of IGF1 mRNA
CTD
PMID:15925091 PMID:19350480 PMID:21190954
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
EXP
estradiol 3-benzoate results in increased expression of IGFBP3 mRNA
CTD
PMID:32741896
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igh-6
immunoglobulin heavy chain 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGH-6 mRNA
CTD
PMID:32741896
G
Igkv2-112l2
immunoglobulin kappa variable 2-112 like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGKV2-112L2 mRNA
CTD
PMID:32741896
NCBI chr 4:102,208,069...102,208,647
Ensembl chr 4:102,208,044...102,208,785
G
Igkv28
immunoglobulin kappa chain variable 28
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGKV28 mRNA
CTD
PMID:32741896
NCBI chr 4:101,302,903...101,303,452
G
Igkvl15
immunoglobulin kappa variable like 15
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGKVL15 mRNA
CTD
PMID:32741896
NCBI chr19:3,093,174...3,093,807
Ensembl chr19:3,093,182...3,093,807
G
Iglc1
immunoglobulin lambda constant 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGLL1 mRNA
CTD
PMID:32741896
NCBI chr11:81,947,966...81,949,822
Ensembl chr11:81,947,934...81,949,822
G
Igsf10
immunoglobulin superfamily, member 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF10 mRNA
CTD
PMID:32741896
NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
G
Igsf6
immunoglobulin superfamily, member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF6 mRNA
CTD
PMID:32741896
NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722
G
Igsf7 l1
immunoglobulin superfamily, member 7 like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IGSF7 L1 mRNA
CTD
PMID:32741896
NCBI chr10:100,174,955...100,182,713
Ensembl chr10:100,156,238...100,182,647
G
Igsf9
immunoglobulin superfamily, member 9
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of IGSF9 promoter
CTD
PMID:27415467
NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607
G
Ikzf1
IKAROS family zinc finger 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IKZF1 mRNA
CTD
PMID:32741896
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il10
interleukin 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL10 mRNA
CTD
PMID:32741896
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il10ra
interleukin 10 receptor subunit alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL10RA mRNA
CTD
PMID:32741896
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1A mRNA
CTD
PMID:32741896
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1B mRNA; methyl palmitate inhibits the reaction [estradiol 3-benzoate results in increased expression of IL1B protein]
CTD
PMID:32741896 PMID:32967526
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1R2 mRNA
CTD
PMID:32741896
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL1RN mRNA
CTD
PMID:32741896
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il21r
interleukin 21 receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA
CTD
PMID:32741896
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
Il27ra
interleukin 27 receptor subunit alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA
CTD
PMID:32741896
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Il2ra
interleukin 2 receptor subunit alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL2RA mRNA
CTD
PMID:32741896
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il36b
interleukin 36, beta
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL36B mRNA
CTD
PMID:32741896
NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:7,021,973...7,031,619
G
Il7r
interleukin 7 receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL7R mRNA
CTD
PMID:32741896
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Inhbb
inhibin subunit beta B
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of INHBB mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INHBB mRNA
CTD
PMID:32741896
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Inpp5d
inositol polyphosphate-5-phosphatase D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INPP5D mRNA
CTD
PMID:32741896
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Ip6k1
inositol hexakisphosphate kinase 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of IP6K1 promoter
CTD
PMID:27415467
NCBI chr 8:108,693,068...108,737,278
G
Irag2
inositol 1,4,5-triphosphate receptor associated 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRAG2 mRNA
CTD
PMID:32741896
NCBI chr 4:178,088,902...178,143,569
Ensembl chr 4:178,088,507...178,143,557
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:32741896
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
G
Irak3
interleukin-1 receptor-associated kinase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRAK3 mRNA
CTD
PMID:32741896
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Irf4
interferon regulatory factor 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF4 mRNA
CTD
PMID:32741896
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irf7
interferon regulatory factor 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRF7 mRNA
CTD
PMID:32741896
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irgm
immunity-related GTPase M
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IRGM mRNA
CTD
PMID:32741896
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Isg15
ISG15 ubiquitin-like modifier
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ISG15 mRNA
CTD
PMID:32741896
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Itga4
integrin subunit alpha 4
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of ITGA4 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGA4 mRNA
CTD
PMID:32741896
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itga8
integrin subunit alpha 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGA8 mRNA
CTD
PMID:32741896
NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510
G
Itgam
integrin subunit alpha M
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGAM mRNA
CTD
PMID:32741896
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgax
integrin subunit alpha X
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGAX mRNA
CTD
PMID:32741896
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itgb2
integrin subunit beta 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA
CTD
PMID:32741896
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Itgb7
integrin subunit beta 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB7 mRNA
CTD
PMID:32741896
NCBI chr 7:133,347,927...133,364,955
Ensembl chr 7:133,347,960...133,364,876
G
Izumo1r
IZUMO1 receptor, JUNO
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IZUMO1R mRNA
CTD
PMID:32741896
NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:11,725,863...11,748,465
G
Jchain
joining chain of multimeric IgA and IgM
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of JCHAIN mRNA
CTD
PMID:32741896
NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
G
Jph3
junctophilin 3
increases expression
EXP
estradiol 3-benzoate results in increased expression of JPH3 mRNA
CTD
PMID:32741896
NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338
G
Katnal2
katanin catalytic subunit A1 like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of KATNAL2 mRNA
CTD
PMID:32741896
NCBI chr18:70,531,759...70,607,886
Ensembl chr18:70,531,754...70,608,082
G
Katnb1
katanin regulatory subunit B1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of KATNB1 promoter
CTD
PMID:27415467
NCBI chr19:9,921,216...9,940,853
Ensembl chr19:9,921,219...9,940,650
G
Kcnd1
potassium voltage-gated channel subfamily D member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCND1 mRNA
CTD
PMID:32741896
NCBI chr X:14,661,688...14,678,745
Ensembl chr X:14,662,357...14,677,233
G
Kcnk2
potassium two pore domain channel subfamily K member 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of KCNK2 promoter
CTD
PMID:27415467
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnk7
potassium two pore domain channel subfamily K member 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCNK7 mRNA
CTD
PMID:32741896
NCBI chr 1:202,988,801...202,992,842
Ensembl chr 1:202,990,198...202,992,872
G
Kcnq1
potassium voltage-gated channel subfamily Q member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCNQ1 mRNA
CTD
PMID:32741896
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
G
Kcnt1
potassium sodium-activated channel subfamily T member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KCNT1 mRNA
CTD
PMID:32741896
NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667
G
Kif18b
kinesin family member 18B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KIF18B mRNA
CTD
PMID:32741896
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
G
Kif20a
kinesin family member 20A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KIF20A mRNA
CTD
PMID:32741896
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif6
kinesin family member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of KIF6 mRNA
CTD
PMID:32741896
NCBI chr 9:11,076,203...11,373,205
Ensembl chr 9:11,072,824...11,373,006
G
Kiss1
KiSS-1 metastasis-suppressor
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of KISS1 mRNA; estradiol 3-benzoate results in decreased expression of KISS1 protein
CTD
PMID:19106226 PMID:19442818 PMID:20951797 PMID:21190954 PMID:22016562
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
G
Kiss1r
KISS1 receptor
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of KISS1R mRNA
CTD
PMID:21277884
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Klhl12
kelch-like family member 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of KLHL12 mRNA
CTD
PMID:32741896
NCBI chr13:45,899,913...45,933,648
Ensembl chr13:45,899,928...45,933,643
G
Klhl3
kelch-like family member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLHL3 mRNA
CTD
PMID:32741896
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
G
Klhl6
kelch-like family member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLHL6 mRNA
CTD
PMID:32741896
NCBI chr11:80,970,917...81,010,593
Ensembl chr11:80,970,917...81,009,677
G
Klrc1
killer cell lectin like receptor C1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRC1 mRNA
CTD
PMID:32741896
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
G
Klrc2
killer cell lectin like receptor C2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRC2 mRNA
CTD
PMID:32741896
NCBI chr 4:163,122,700...163,133,843
Ensembl chr 4:163,122,704...163,133,843
G
Klrc3
killer cell lectin like receptor C3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRC3 mRNA
CTD
PMID:32741896
NCBI chr 4:163,105,081...163,112,737
Ensembl chr 4:163,106,024...163,112,336
G
Klrd1
killer cell lectin like receptor D1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KLRD1 mRNA
CTD
PMID:32741896
NCBI chr 4:163,044,920...163,056,568
Ensembl chr 4:163,045,067...163,056,518
G
Kmo
kynurenine 3-monooxygenase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KMO mRNA
CTD
PMID:32741896
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Kng1
kininogen 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNG1 mRNA
CTD
PMID:32741896
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Kng2l1
kininogen 2-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNG2L1 mRNA
CTD
PMID:32741896
NCBI chr11:77,978,795...78,002,976
Ensembl chr11:77,909,612...78,002,971
G
Knl1
kinetochore scaffold 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNL1 mRNA
CTD
PMID:32741896
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNSTRN mRNA
CTD
PMID:32741896
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Krt20
keratin 20
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT20 mRNA
CTD
PMID:32741896
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
G
Krt25
keratin 25
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of KRT25 promoter
CTD
PMID:27415467
NCBI chr10:84,267,399...84,275,025
Ensembl chr10:84,267,399...84,274,965
G
Krt36
keratin 36
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA
CTD
PMID:32741896
NCBI chr10:85,036,379...85,040,003
Ensembl chr10:85,036,594...85,039,959
G
Krt7
keratin 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT7 mRNA
CTD
PMID:32741896
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt8
keratin 8
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of KRT8 promoter
CTD
PMID:27415467
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Krt87
keratin 87
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of KRT83 promoter
CTD
PMID:27415467
NCBI chr 7:132,547,388...132,555,005
Ensembl chr 7:132,548,141...132,554,978
G
Krtap16-5
keratin associated protein 16-5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRTAP16-5 mRNA
CTD
PMID:32741896
NCBI chr11:28,249,212...28,249,796
Ensembl chr11:28,249,212...28,249,796
G
Lacc1
laccase domain containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LACC1 mRNA
CTD
PMID:32741896
NCBI chr15:52,390,267...52,407,630
Ensembl chr15:52,395,183...52,407,545
G
Lag3
lymphocyte activating 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAG3 mRNA
CTD
PMID:32741896
NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404
G
Lamb1
laminin subunit beta 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of LAMB1 mRNA
CTD
PMID:32741896
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
G
Laptm5
lysosomal protein transmembrane 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAPTM5 mRNA
CTD
PMID:32741896
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lat2
linker for activation of T cells family, member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAT2 mRNA
CTD
PMID:32741896
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Lbp
lipopolysaccharide binding protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LBP mRNA
CTD
PMID:32741896
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lcn2
lipocalin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA
CTD
PMID:32741896
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lcp2
lymphocyte cytosolic protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCP2 mRNA
CTD
PMID:32741896
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
G
Ldlrad2
low density lipoprotein receptor class A domain containing 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of LDLRAD2 mRNA
CTD
PMID:32741896
NCBI chr 5:149,778,795...149,788,335
Ensembl chr 5:149,779,675...149,787,140
G
Lepr
leptin receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LEPR mRNA
CTD
PMID:32741896
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lgals3bp
galectin 3 binding protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS3BP mRNA
CTD
PMID:32741896
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lgals9
galectin 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS9 mRNA
CTD
PMID:32741896
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lgi2
leucine-rich repeat LGI family, member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGI2 mRNA
CTD
PMID:32741896
NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407
G
Lhb
luteinizing hormone subunit beta
decreases expression multiple interactions increases secretion decreases secretion
ISO EXP
estradiol 3-benzoate results in decreased expression of LHB mRNA [estradiol 3-benzoate co-treated with Progesterone] results in increased abundance of LHB protein estradiol 3-benzoate results in increased secretion of LHB protein Atrazine inhibits the reaction [[estradiol 3-benzoate co-treated with Progesterone] results in increased secretion of LHB protein]; Atrazine inhibits the reaction [estradiol 3-benzoate results in increased secretion of LHB protein]; Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased secretion of LHB protein]; Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased secretion of LHB protein]
CTD
PMID:10696778 PMID:15056801 PMID:15223135 PMID:16614383 PMID:17398000 PMID:22577852 PMID:24316378 More...
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
increases expression
ISO
estradiol 3-benzoate results in increased expression of LHCGR mRNA
CTD
PMID:15223135
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
G
Lhx8
LIM homeobox 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LHX8 mRNA
CTD
PMID:32741896
NCBI chr 2:243,244,958...243,269,624
Ensembl chr 2:243,244,961...243,269,416
G
Lilra5
leukocyte immunoglobulin like receptor A5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRA5 mRNA
CTD
PMID:32741896
NCBI chr 1:69,973,292...69,978,750
Ensembl chr 1:69,973,292...70,001,718
G
Lilrb4
leukocyte immunoglobulin like receptor B4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRB4 mRNA
CTD
PMID:32741896
NCBI chr 1:69,805,020...69,810,628
Ensembl chr 1:69,805,250...69,810,660
G
Lilrc2
leukocyte immunoglobulin-like receptor, subfamily C, member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRC2 mRNA
CTD
PMID:32741896
NCBI chr 1:65,272,134...65,277,278
Ensembl chr 1:65,272,796...65,277,271
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
increases expression
EXP
estradiol 3-benzoate results in increased expression of LIN7A mRNA
CTD
PMID:32741896
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lipg
lipase G, endothelial type
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of LIPG mRNA
CTD
PMID:32741896
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lix1
limb and CNS expressed 1
increases expression
EXP
estradiol 3-benzoate results in increased expression of LIX1 mRNA
CTD
PMID:32741896
NCBI chr 1:58,128,961...58,187,554
Ensembl chr 1:58,128,961...58,185,964
G
Loxl1
lysyl oxidase-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LOXL1 mRNA
CTD
PMID:32741896
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lrcol1
leucine rich colipase-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LRCOL1 mRNA
CTD
PMID:32741896
NCBI chr12:46,326,049...46,339,475
Ensembl chr12:46,326,077...46,337,953
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRG1 mRNA
CTD
PMID:32741896
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Lrrc1
leucine rich repeat containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LRRC1 mRNA
CTD
PMID:32741896
NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
G
Lrrc15
leucine rich repeat containing 15
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of LRRC15 promoter
CTD
PMID:27415467
NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267
G
Lrrc17
leucine rich repeat containing 17
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC17 mRNA
CTD
PMID:32741896
NCBI chr 4:13,501,428...13,531,845
Ensembl chr 4:13,501,436...13,531,845
G
Lrrc18
leucine rich repeat containing 18
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of LRRC18 promoter
CTD
PMID:27415467
NCBI chr16:8,253,524...8,277,141
Ensembl chr16:8,254,352...8,277,437
G
Lrrc4
leucine rich repeat containing 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC4 mRNA
CTD
PMID:32741896
NCBI chr 4:57,433,518...57,437,114
Ensembl chr 4:57,433,428...57,437,911
G
Lrrc73
leucine rich repeat containing 73
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of LRRC73 mRNA
CTD
PMID:32741896
NCBI chr 9:14,726,157...14,730,144
Ensembl chr 9:14,726,158...14,729,158
G
Lrrc74a
leucine rich repeat containing 74A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC74A mRNA
CTD
PMID:32741896
NCBI chr 6:106,386,276...106,417,112
Ensembl chr 6:106,386,347...106,416,193
G
Lrrn4cl
LRRN4 C-terminal like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRN4CL mRNA
CTD
PMID:32741896
NCBI chr 1:205,743,580...205,759,879
G
LRRTM1
leucine rich repeat transmembrane neuronal 1
increases expression
EXP
estradiol 3-benzoate results in increased expression of LRRTM1 mRNA
CTD
PMID:32741896
NCBI chr 4:109,701,815...109,718,924
Ensembl chr 4:109,701,815...109,717,184
G
Lsp1
lymphocyte-specific protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LSP1 mRNA
CTD
PMID:32741896
NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416
G
Lst1
leukocyte specific transcript 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LST1 mRNA
CTD
PMID:32741896
NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
G
Ltbp2
latent transforming growth factor beta binding protein 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of LTBP2 promoter
CTD
PMID:27415467
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Ltk
leukocyte receptor tyrosine kinase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LTK mRNA
CTD
PMID:32741896
NCBI chr 3:106,734,675...106,741,552
Ensembl chr 3:106,734,676...106,743,369
G
Ly49i7
Ly49 inhibitory receptor 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49I7 mRNA
CTD
PMID:32741896
NCBI chr 4:164,853,287...164,871,902
Ensembl chr 4:164,853,574...164,867,333
G
Ly49i9
Ly49 inhibitory receptor 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49I9 mRNA
CTD
PMID:32741896
G
Ly49s3
Ly-49 stimulatory receptor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49S3 mRNA
CTD
PMID:32741896
Ensembl chr 4:164,122,072...164,341,692
G
Ly49s6
Ly49 stimulatory receptor 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49S6 mRNA
CTD
PMID:32741896
NCBI chr 4:164,080,442...164,104,904
Ensembl chr 4:163,884,837...164,104,899 Ensembl chr 4:163,884,837...164,104,899
G
Ly49si1
immunoreceptor Ly49si1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49SI1 mRNA
CTD
PMID:32741896
NCBI chr 4:163,586,930...163,600,528
Ensembl chr 4:163,514,541...163,751,214
G
Ly49si2
immunoreceptor Ly49si2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY49SI2 mRNA
CTD
PMID:32741896
NCBI chr 4:163,672,025...163,845,961
Ensembl chr 4:163,514,541...163,751,214
G
Ly6a
lymphocyte antigen 6 family member A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6AL mRNA
CTD
PMID:32741896
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
G
Ly6c
Ly6-C antigen
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6C mRNA
CTD
PMID:32741896
NCBI chr 7:106,959,508...106,963,329
Ensembl chr 7:106,959,511...106,963,329
G
Ly6cl1
Ly6-C antigen like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6CL1 mRNA
CTD
PMID:32741896
NCBI chr 7:107,122,197...107,163,755
Ensembl chr 7:107,011,588...107,163,788
G
Ly6e
lymphocyte antigen 6 family member E
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6E mRNA
CTD
PMID:32741896
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
G
Ly6l
lymphocyte antigen 6 family member L
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6L mRNA
CTD
PMID:32741896
NCBI chr 7:107,220,612...107,222,692
Ensembl chr 7:107,141,903...107,143,843
G
Ly86
lymphocyte antigen 86
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY86 mRNA
CTD
PMID:32741896
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
G
Lyl1
LYL1, basic helix-loop-helix family member
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYL1 mRNA
CTD
PMID:32741896
NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007
G
Lynx1
Ly6/neurotoxin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYNX1 mRNA
CTD
PMID:32741896
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:106,632,797...106,638,023
G
Lypd8
Ly6/Plaur domain containing 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYPD8 mRNA
CTD
PMID:32741896
NCBI chr10:42,561,834...42,572,684
Ensembl chr10:42,561,816...42,572,683
G
Lyz2
lysozyme 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LYZ2 mRNA
CTD
PMID:32741896
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Macrod2
mono-ADP ribosylhydrolase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MACROD2 mRNA
CTD
PMID:32741896
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
G
Maf
MAF bZIP transcription factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MAF mRNA
CTD
PMID:32741896
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Mall
mal, T-cell differentiation protein-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MALL mRNA
CTD
PMID:32741896
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
G
Man1c1
mannosidase, alpha, class 1C, member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MAN1C1 mRNA
CTD
PMID:32741896
NCBI chr 5:146,774,282...146,913,257
Ensembl chr 5:146,775,842...146,913,421
G
Map2k1
mitogen activated protein kinase kinase 1
decreases phosphorylation
EXP
estradiol 3-benzoate results in decreased phosphorylation of MAP2K1 protein
CTD
PMID:15778002
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Map2k2
mitogen activated protein kinase kinase 2
decreases phosphorylation
EXP
estradiol 3-benzoate results in decreased phosphorylation of MAP2K2 protein
CTD
PMID:15778002
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
EXP
estradiol 3-benzoate results in decreased phosphorylation of MAPK1 protein
CTD
PMID:15778002
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
EXP
estradiol 3-benzoate results in decreased phosphorylation of MAPK3 protein
CTD
PMID:15778002
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Marchf10
membrane associated ring-CH-type finger 10
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of MARCHF10 promoter
CTD
PMID:27415467
NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588
G
Marcksl1
MARCKS-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MARCKSL1 mRNA
CTD
PMID:32741896
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Mcemp1
mast cell-expressed membrane protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCEMP1 mRNA
CTD
PMID:32741896
NCBI chr12:1,721,781...1,727,350
Ensembl chr12:1,718,730...1,725,986
G
Mcm3
minichromosome maintenance complex component 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA
CTD
PMID:32741896
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcoln2
mucolipin TRP cation channel 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN2 mRNA
CTD
PMID:32741896
NCBI chr 2:235,053,816...235,102,703
Ensembl chr 2:235,053,816...235,102,702
G
Mcoln3
mucolipin TRP cation channel 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN3 mRNA
CTD
PMID:32741896
NCBI chr 2:235,008,716...235,042,885
Ensembl chr 2:234,966,010...235,043,047
G
Mfap2
microfibril associated protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA
CTD
PMID:32741896
NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259
G
Mgam
maltase-glucoamylase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MGAM mRNA
CTD
PMID:32741896
NCBI chr 4:69,441,626...69,602,068
Ensembl chr 4:69,446,150...69,692,715
G
Milr1
mast cell immunoglobulin-like receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MILR1 mRNA
CTD
PMID:32741896
NCBI chr10:91,684,288...91,705,284
Ensembl chr10:91,687,831...91,705,282
G
Mir615
microRNA 615
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of MIR615 promoter
CTD
PMID:27415467
NCBI chr 7:134,151,887...134,151,978
Ensembl chr 7:134,151,887...134,151,978
G
Mki67
marker of proliferation Ki-67
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA
CTD
PMID:32741896
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp16
matrix metallopeptidase 16
increases expression
EXP
estradiol 3-benzoate results in increased expression of MMP16 mRNA
CTD
PMID:32741896
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
G
Mmp2
matrix metallopeptidase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MMP2 mRNA
CTD
PMID:32741896
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp28
matrix metallopeptidase 28
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MMP28 mRNA
CTD
PMID:32741896
NCBI chr10:68,241,138...68,264,866
Ensembl chr10:68,241,138...68,264,866
G
Mmp8
matrix metallopeptidase 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MMP8 mRNA
CTD
PMID:32741896
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mnda
myeloid cell nuclear differentiation antigen
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA estradiol 3-benzoate results in increased expression of MNDA mRNA
CTD
PMID:32741896
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mpeg1
macrophage expressed 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MPEG1 mRNA
CTD
PMID:32741896
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
G
Mpo
myeloperoxidase
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [estradiol 3-benzoate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]]; estradiol 3-benzoate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]
CTD
PMID:27363640
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mpz
myelin protein zero
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MPZ mRNA
CTD
PMID:32741896
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
G
Mrc1
mannose receptor, C type 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MRC1 mRNA
CTD
PMID:32741896
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Mrgprx3
MAS related GPR family member X3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MRGPRX3 mRNA
CTD
PMID:32741896
NCBI chr 1:97,720,377...97,746,953
Ensembl chr 1:97,721,436...97,746,900
G
Ms4a1
membrane spanning 4-domains A1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A1 mRNA
CTD
PMID:32741896
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
G
Ms4a10
membrane spanning 4-domains A10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A10 mRNA
CTD
PMID:32741896
NCBI chr 1:207,611,312...207,624,452
Ensembl chr 1:207,611,312...207,624,452
G
Ms4a12
membrane spanning 4-domains A12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A12 mRNA
CTD
PMID:32741896
NCBI chr 1:207,881,065...207,894,633
Ensembl chr 1:207,882,333...207,893,938
G
Ms4a18
membrane spanning 4-domains A18
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A18 mRNA
CTD
PMID:32741896
NCBI chr 1:207,644,858...207,662,471
Ensembl chr 1:207,645,780...207,665,793
G
Ms4a4a
membrane spanning 4-domains A4A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A4E mRNA
CTD
PMID:32741896
NCBI chr 1:208,060,507...208,085,121
Ensembl chr 1:208,046,971...208,085,119
G
Ms4a6a
membrane spanning 4-domains A6A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6A mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6E mRNA
CTD
PMID:32741896
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
G
Ms4a6bl1
membrane-spanning 4-domains, subfamily A, member 6B-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A6BL1 mRNA
CTD
PMID:32741896
NCBI chr 1:208,243,561...208,255,400
Ensembl chr 1:208,243,559...208,257,340
G
Ms4a7
membrane spanning 4-domains A7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA
CTD
PMID:32741896
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
G
Msc
musculin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA
CTD
PMID:32741896
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
G
Msln
mesothelin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSLN mRNA
CTD
PMID:32741896
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Mstn
myostatin
multiple interactions decreases expression
EXP
estradiol 3-benzoate promotes the reaction [Progesterone results in decreased expression of MSTN mRNA] estradiol 3-benzoate results in decreased expression of MSTN mRNA
CTD
PMID:18845635
NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933
G
Mt3
metallothionein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MT3 mRNA
CTD
PMID:32741896
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Mt4
metallothionein 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MT4 mRNA
CTD
PMID:32741896
NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909
G
Mthfd2l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MTHFD2L mRNA
CTD
PMID:32741896
NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112
G
Mx1
MX dynamin like GTPase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MX1 mRNA
CTD
PMID:32741896
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYCN mRNA
CTD
PMID:32741896
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Myh9
myosin, heavy chain 9
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of MYH9 promoter
CTD
PMID:27415467
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
G
Mylk3
myosin light chain kinase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA
CTD
PMID:32741896
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
G
Myo1f
myosin IF
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYO1F mRNA
CTD
PMID:32741896
NCBI chr 7:14,363,340...14,413,911
Ensembl chr 7:14,363,350...14,413,911
G
Myo7a
myosin VIIA
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYO7A mRNA
CTD
PMID:32741896
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
G
Mzb1
marginal zone B and B1 cell-specific protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MZB1 mRNA
CTD
PMID:32741896
NCBI chr18:27,238,999...27,241,060
Ensembl chr18:27,239,001...27,241,094
G
N4bp2l2
NEDD4 binding protein 2-like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of N4BP2L2 mRNA
CTD
PMID:32741896
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
Naaa
N-acylethanolamine acid amidase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAAA mRNA
CTD
PMID:32741896
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
G
Napepld
N-acyl phosphatidylethanolamine phospholipase D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAPEPLD mRNA
CTD
PMID:32741896
NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748
G
Napsa
napsin A aspartic peptidase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAPSA mRNA
CTD
PMID:32741896
NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:95,064,900...95,077,094
G
Nav3
neuron navigator 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAV3 mRNA
CTD
PMID:32741896
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
G
Ncam1
neural cell adhesion molecule 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NCAM1 mRNA
CTD
PMID:32741896
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF1 mRNA
CTD
PMID:32741896
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf4
neutrophil cytosolic factor 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF4 mRNA
CTD
PMID:32741896
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
G
Nckap1l
NCK associated protein 1 like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCKAP1L mRNA
CTD
PMID:32741896
NCBI chr 7:134,577,470...134,622,928
Ensembl chr 7:134,577,482...134,622,934
G
Ndc80
NDC80 kinetochore complex component
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NDC80 mRNA
CTD
PMID:32741896
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Ndfip2
Nedd4 family interacting protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NDFIP2 mRNA
CTD
PMID:32741896
NCBI chr15:82,032,366...82,087,043
Ensembl chr15:82,032,366...82,086,317
G
Necab2
N-terminal EF-hand calcium binding protein 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of NECAB2 promoter
CTD
PMID:27415467
NCBI chr19:47,501,351...47,527,722
Ensembl chr19:47,501,302...47,527,684
G
Nek6
NIMA-related kinase 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NEK6 mRNA
CTD
PMID:32741896
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Nell2
neural EGFL like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NELL2 mRNA
CTD
PMID:32741896
NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NEURL3 mRNA
CTD
PMID:32741896
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Nfam1
NFAT activating protein with ITAM motif 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NFAM1 mRNA
CTD
PMID:32741896
NCBI chr 7:114,139,318...114,175,395
Ensembl chr 7:114,139,345...114,175,442
G
Nfe2
nuclear factor, erythroid 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NFE2 mRNA
CTD
PMID:32741896
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
G
Nfia
nuclear factor I/A
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of NFIA promoter
CTD
PMID:27415467
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
G
Nfkbid
NFKB inhibitor delta
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NFKBID mRNA
CTD
PMID:32741896
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
G
Nkain3
Sodium/potassium transporting ATPase interacting 3
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of NKAIN3 gene
CTD
PMID:35026373
NCBI chr 5:33,613,720...34,310,090
Ensembl chr 5:33,623,713...34,309,381
G
Nkd1
NKD inhibitor of WNT signaling pathway 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKD1 mRNA
CTD
PMID:32741896
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
G
Nkg7
natural killer cell granule protein 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NKG7 mRNA
CTD
PMID:32741896
NCBI chr 1:93,844,748...93,845,975
Ensembl chr 1:93,844,902...93,845,983
G
Nkx1-2
NK1 homeobox 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKX1-2 mRNA
CTD
PMID:32741896
NCBI chr 1:187,386,370...187,391,252
Ensembl chr 1:187,388,711...187,391,149
G
Nlrc3
NLR family, CARD domain containing 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC3 mRNA
CTD
PMID:32741896
NCBI chr10:11,551,378...11,585,027
Ensembl chr10:11,551,356...11,584,398
G
Nlrc5
NLR family, CARD domain containing 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRC5 mRNA
CTD
PMID:32741896
NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
G
Nlrp12
NLR family, pyrin domain containing 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRP12 mRNA
CTD
PMID:32741896
NCBI chr 1:65,932,610...65,969,873
Ensembl chr 1:65,932,595...65,960,934
G
Nlrp1a
NLR family, pyrin domain containing 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRP1A mRNA
CTD
PMID:32741896
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NLRP3 mRNA
CTD
PMID:32741896
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nol10
nucleolar protein 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NOL10 mRNA
CTD
PMID:32741896
NCBI chr 6:40,144,217...40,225,353
Ensembl chr 6:40,144,235...40,225,353
G
Nos1
nitric oxide synthase 1
multiple interactions
EXP
[Progesterone co-treated with estradiol 3-benzoate] results in increased expression of NOS1 protein
CTD
PMID:15347845
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nox4
NADPH oxidase 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NOX4 mRNA
CTD
PMID:32741896
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Noxo1
NADPH oxidase organizer 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NOXO1 mRNA
CTD
PMID:32741896
NCBI chr10:13,723,253...13,726,008
Ensembl chr10:13,721,473...13,726,061
G
Np4
defensin NP-4 precursor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NP4 mRNA
CTD
PMID:32741896
NCBI chr16:70,494,607...70,497,261
Ensembl chr16:70,342,529...70,497,202
G
Npr1
natriuretic peptide receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NPR1 mRNA
CTD
PMID:32741896
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
G
Npy4r
neuropeptide Y receptor Y4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NPY4R mRNA
CTD
PMID:32741896
NCBI chr16:9,467,801...9,469,057
Ensembl chr16:9,467,801...9,469,057
G
Nr2e3
nuclear receptor subfamily 2, group E, member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NR2E3 mRNA
CTD
PMID:32741896
NCBI chr 8:60,365,581...60,373,383
Ensembl chr 8:60,366,124...60,373,163
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA
CTD
PMID:32741896
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Nrgn
neurogranin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NRGN mRNA
CTD
PMID:32741896
NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516
G
Nrp1
neuropilin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NRP1 mRNA
CTD
PMID:32741896
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrtn
neurturin
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of NRTN promoter
CTD
PMID:27415467
NCBI chr 9:1,581,860...1,587,835
Ensembl chr 9:1,581,975...1,583,102
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of NSMF mRNA
CTD
PMID:32741896
NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
G
Nuggc
nuclear GTPase, germinal center associated
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of NUGGC mRNA
CTD
PMID:32741896
NCBI chr15:39,821,851...39,866,122
Ensembl chr15:39,821,855...39,866,122
G
Nxpe5l3
neurexophilin and PC-esterase domain family, member 5 like 3
increases expression
EXP
estradiol 3-benzoate results in increased expression of NXPE5L3 mRNA
CTD
PMID:32741896
NCBI chr12:17,238,311...17,252,723
Ensembl chr12:17,245,783...17,252,723
G
Nxph3
neurexophilin 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NXPH3 mRNA
CTD
PMID:32741896
NCBI chr10:80,456,283...80,459,949
Ensembl chr10:80,455,429...80,462,415
G
Oas1i
2 ' -5 ' oligoadenylate synthetase 1I
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OAS1I mRNA
CTD
PMID:32741896
NCBI chr12:35,624,566...35,636,608
Ensembl chr12:35,624,592...35,636,604
G
Oas1k
2 ' -5 ' oligoadenylate synthetase 1K
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OAS1K mRNA
CTD
PMID:32741896
NCBI chr12:35,762,483...35,771,710
Ensembl chr12:35,762,468...35,771,710
G
Oas2
2'-5' oligoadenylate synthetase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OAS2 mRNA
CTD
PMID:32741896
NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371
G
Oasl
2'-5'-oligoadenylate synthetase-like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OASL mRNA
CTD
PMID:32741896
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Obp1f
odorant binding protein I f
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of OBP1F mRNA
CTD
PMID:32741896
NCBI chr X:41,955,618...41,960,681
Ensembl chr X:41,955,618...41,960,681
G
Obp2a
odorant binding protein 2A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OBP2A mRNA
CTD
PMID:32741896
NCBI chr 3:8,505,963...8,509,269
Ensembl chr 3:8,505,990...8,509,269
G
Obscn
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OBSCN mRNA
CTD
PMID:32741896
NCBI chr10:43,774,113...43,919,718
Ensembl chr10:43,789,293...43,919,723
G
Ocln
occludin
increases expression multiple interactions
ISO EXP
estradiol 3-benzoate results in increased expression of OCLN mRNA; estradiol 3-benzoate results in increased expression of OCLN protein fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA]; fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN protein]
CTD
PMID:19433574
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
affects expression
EXP
estradiol 3-benzoate affects the expression of ODC1 mRNA
CTD
PMID:15925091
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Olr1
oxidized low density lipoprotein receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OLR1 mRNA
CTD
PMID:32741896
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Or2b11
olfactory receptor family 2 subfamily B member 11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OR2B11 mRNA
CTD
PMID:32741896
NCBI chr10:44,358,397...44,359,353
Ensembl chr10:44,357,668...44,362,937
G
Osbpl6
oxysterol binding protein-like 6
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of OSBPL6 promoter
CTD
PMID:27415467
NCBI chr 3:61,343,776...61,541,170
Ensembl chr 3:61,343,809...61,537,102
G
Osm
oncostatin M
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OSM mRNA
CTD
PMID:32741896
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Osr2
odd-skipped related transciption factor 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of OSR2 promoter
CTD
PMID:27415467
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
G
Ovol1
ovo like transcriptional repressor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of OVOL1 mRNA
CTD
PMID:32741896
NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831
G
Oxgr1
oxoglutarate receptor 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of OXGR1 promoter
CTD
PMID:27415467
NCBI chr15:97,145,947...97,146,960
Ensembl chr15:97,144,293...97,166,612
G
P2rx3
purinergic receptor P2X 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of P2RX3 mRNA
CTD
PMID:32741896
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
P2ry12
purinergic receptor P2Y12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY12 mRNA
CTD
PMID:32741896
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
G
P2ry13
purinergic receptor P2Y13
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA
CTD
PMID:32741896
NCBI chr 2:143,470,437...143,476,360
Ensembl chr 2:143,470,425...143,473,434
G
Padi2
peptidyl arginine deiminase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PADI2 mRNA
CTD
PMID:32741896
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
G
Pank1
pantothenate kinase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA
CTD
PMID:32741896
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Paqr4
progestin and adipoQ receptor family member 4
decreases methylation increases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased methylation of PAQR4 promoter estradiol 3-benzoate results in increased expression of PAQR4 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PAQR4 mRNA
CTD
PMID:27415467 PMID:28728135 PMID:32741896
NCBI chr10:12,758,970...12,762,649
Ensembl chr10:12,758,972...12,762,584
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
EXP
estradiol 3-benzoate results in increased cleavage of PARP1 protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased cleavage of PARP1 protein]
CTD
PMID:24316378
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp12
poly (ADP-ribose) polymerase family, member 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARP12 mRNA
CTD
PMID:32741896
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
G
Parp14
poly (ADP-ribose) polymerase family, member 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARP14 mRNA
CTD
PMID:32741896
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
G
Parpbp
PARP1 binding protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARPBP mRNA
CTD
PMID:32741896
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
G
Parvg
parvin, gamma
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARVG mRNA
CTD
PMID:32741896
NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:115,456,209...115,475,104
G
Pax9
paired box 9
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of PAX9 promoter
CTD
PMID:27415467
NCBI chr 6:74,186,749...74,203,508
Ensembl chr 6:74,182,568...74,203,506
G
Pcdh17
protocadherin 17
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA
CTD
PMID:32741896
NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999
G
Pcdha13
protocadherin alpha 13
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PCDHA13 promoter
CTD
PMID:27415467
Ensembl chr18:28,581,225...28,846,211
G
Pcna
proliferating cell nuclear antigen
increases expression
EXP
estradiol 3-benzoate results in increased expression of PCNA mRNA; estradiol 3-benzoate results in increased expression of PCNA protein
CTD
PMID:27830003
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdcd1
programmed cell death 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PDCD1 mRNA
CTD
PMID:32741896
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pde3a
phosphodiesterase 3A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PDE3A mRNA
CTD
PMID:32741896
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pde7a
phosphodiesterase 7A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PDE7A mRNA
CTD
PMID:32741896
NCBI chr 2:101,714,767...101,806,853
Ensembl chr 2:101,718,444...101,806,681
G
Pdgfra
platelet derived growth factor receptor alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PDGFRA mRNA
CTD
PMID:32741896
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pga5
pepsinogen A5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PGA5 mRNA
CTD
PMID:32741896
NCBI chr 1:207,317,021...207,327,156
Ensembl chr 1:207,317,021...207,327,156
G
Pglyrp1
peptidoglycan recognition protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PGLYRP1 mRNA
CTD
PMID:32741896
NCBI chr 1:78,531,815...78,537,001
Ensembl chr 1:78,531,815...78,537,001
G
Pgr
progesterone receptor
increases expression
EXP
estradiol 3-benzoate results in increased expression of PGR mRNA; estradiol 3-benzoate results in increased expression of PGR protein; estradiol 3-benzoate results in increased expression of PGR protein alternative form
CTD
PMID:15456929 PMID:15778002 PMID:19574278
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phactr1
phosphatase and actin regulator 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PHACTR1 promoter
CTD
PMID:27415467
NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831
G
Phgr1
proline, histidine and glycine rich 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PHGR1 mRNA
CTD
PMID:32741896
NCBI chr 3:105,742,822...105,760,835
Ensembl chr 3:105,757,581...105,760,832
G
Phospho1
phosphoethanolamine/phosphocholine phosphatase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PHOSPHO1 mRNA
CTD
PMID:32741896
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
G
Phpt1
phosphohistidine phosphatase 1
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of PHPT1 promoter
CTD
PMID:27415467
NCBI chr 3:8,392,926...8,394,325
G
Pigu
phosphatidylinositol glycan anchor biosynthesis, class U
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PIGU mRNA
CTD
PMID:32741896
NCBI chr 3:143,784,831...143,881,268
Ensembl chr 3:143,784,832...143,880,807
G
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PIK3C2G promoter
CTD
PMID:27415467
NCBI chr 4:172,483,752...172,851,623
Ensembl chr 4:172,484,345...172,850,544
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PIK3CD mRNA
CTD
PMID:32741896
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PIK3R1 promoter
CTD
PMID:27415467
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pilrb-ps6
paired immunoglobin-like type 2 receptor beta, pseudogene 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PILRB-PS6 mRNA
CTD
PMID:32741896
NCBI chr12:18,609,055...18,630,916
Ensembl chr12:18,601,158...18,651,608 Ensembl chr12:18,601,158...18,651,608
G
Pilrb2l1
paired immunoglobin like type 2 receptor beta 2 like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PILRB2L1 mRNA
CTD
PMID:32741896
NCBI chr12:17,720,213...17,732,681
Ensembl chr12:17,723,741...17,828,007
G
Pilrb2l3
paired immunoglobin like type 2 receptor beta 2 like 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PILRB2L3 mRNA
CTD
PMID:32741896
NCBI chr12:18,210,535...18,216,471
Ensembl chr12:18,210,535...18,216,443
G
Pinlyp
phospholipase A2 inhibitor and Ly6/Plaur domain containing
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PINLYP mRNA
CTD
PMID:32741896
NCBI chr 1:80,134,642...80,140,488
Ensembl chr 1:80,134,643...80,139,996
G
Pip4k2a
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PIP4K2A mRNA
CTD
PMID:32741896
NCBI chr17:81,496,669...81,668,180
Ensembl chr17:81,496,670...81,668,029
G
Pira12
paired-Ig-like receptor A12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PIRA12 mRNA
CTD
PMID:32741896
NCBI chr 1:65,304,408...65,313,090
G
Pira2
paired-Ig-like receptor A2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PIRA2 mRNA
CTD
PMID:32741896
NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853
G
Pirb
paired Ig-like receptor B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LILRB3 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PIRB mRNA
CTD
PMID:32741896
NCBI chr 1:65,499,195...65,506,666
Ensembl chr 1:65,499,195...65,506,666
G
Pitx3
paired-like homeodomain 3
decreases methylation increases expression
EXP
estradiol 3-benzoate results in decreased methylation of PITX3 promoter estradiol 3-benzoate results in increased expression of PITX3 mRNA
CTD
PMID:27415467
NCBI chr 1:245,001,106...245,013,881
Ensembl chr 1:245,001,164...245,013,892
G
Pkib
cAMP-dependent protein kinase inhibitor beta
increases expression
EXP
estradiol 3-benzoate results in increased expression of PKIB mRNA
CTD
PMID:32741896
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
G
Pla2g2a
phospholipase A2 group IIA
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA
CTD
PMID:32741896
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
G
Pla2g2d
phospholipase A2, group IID
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2D mRNA
CTD
PMID:32741896
NCBI chr 5:151,016,010...151,022,531
Ensembl chr 5:151,018,870...151,022,525
G
Pla2g5
phospholipase A2, group V
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G5 mRNA
CTD
PMID:32741896
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
G
Pla2g7
phospholipase A2 group VII
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G7 mRNA
CTD
PMID:32741896
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plac8
placenta associated 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLAC8 mRNA
CTD
PMID:32741896
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Plat
plasminogen activator, tissue type
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLAT mRNA
CTD
PMID:32741896
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plaur
plasminogen activator, urokinase receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLAUR mRNA
CTD
PMID:32741896
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plbd1
phospholipase B domain containing 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLBD1 mRNA
CTD
PMID:32741896
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plcb2
phospholipase C, beta 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCB2 mRNA
CTD
PMID:32741896
NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302
G
Plcl2
phospholipase C-like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCL2 mRNA
CTD
PMID:32741896
NCBI chr 9:3,292,564...3,477,009
Ensembl chr 9:3,292,695...3,477,009
G
Plcz1
phospholipase C, zeta 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PLCZ1 mRNA
CTD
PMID:32741896
NCBI chr 4:172,873,110...172,929,191
Ensembl chr 4:172,873,112...172,928,358
G
Pld2
phospholipase D2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLD2 mRNA
CTD
PMID:32741896
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
G
Pld4
phospholipase D family, member 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLD4 mRNA
CTD
PMID:32741896
NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376
G
Plek
pleckstrin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLEK mRNA
CTD
PMID:32741896
NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLOD2 mRNA
CTD
PMID:32741896
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
G
Pls1
plastin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLS1 mRNA
CTD
PMID:32741896
NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:96,317,849...96,385,195
G
Pltp
phospholipid transfer protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLTP mRNA
CTD
PMID:32741896
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
G
Plxdc2
plexin domain containing 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA
CTD
PMID:32741896
NCBI chr17:79,169,238...79,594,279
Ensembl chr17:79,196,369...79,585,282
G
Plxnb3
plexin B3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXNB3 mRNA
CTD
PMID:32741896
NCBI chr X:151,493,832...151,508,688
Ensembl chr X:151,494,207...151,508,674
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PMAIP1 mRNA
CTD
PMID:32741896
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pmp22
peripheral myelin protein 22
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PMP22 mRNA
CTD
PMID:32741896
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
G
Pnma8b
PNMA family member 8B
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PNMA8B mRNA estradiol 3-benzoate results in increased expression of PNMA8B mRNA
CTD
PMID:32741896
NCBI chr 1:77,622,287...77,626,525
Ensembl chr 1:77,622,283...77,627,148
G
Podnl1
podocan-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PODNL1 mRNA
CTD
PMID:32741896
NCBI chr19:24,027,261...24,033,867
Ensembl chr19:24,027,297...24,033,846
G
Por
cytochrome p450 oxidoreductase
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of POR protein
CTD
PMID:24752506
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Postn
periostin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA
CTD
PMID:32741896
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Pou2af3
POU class 2 homeobox associating factor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of POU2AF3 mRNA
CTD
PMID:32741896
NCBI chr 8:51,588,237...51,597,114
Ensembl chr 8:51,588,237...51,603,855
G
Pou2f2
POU class 2 homeobox 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POU2F2 mRNA
CTD
PMID:32741896
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
G
Ppm1n
protein phosphatase, Mg2+/Mn2+ dependent 1N
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PPM1N mRNA
CTD
PMID:32741896
NCBI chr 1:78,929,350...78,934,435
Ensembl chr 1:78,929,351...78,932,685
G
Ppp1r16b
protein phosphatase 1, regulatory subunit 16B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PPP1R16B mRNA
CTD
PMID:32741896
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
G
Ppp4r4
protein phosphatase 4, regulatory subunit 4
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of PPP4R4 mRNA
CTD
PMID:32741896
NCBI chr 6:122,663,172...122,753,988
Ensembl chr 6:122,663,344...122,753,384
G
Pram1
PML-RARA regulated adaptor molecule 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRAM1 mRNA
CTD
PMID:32741896
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
G
Prc1
protein regulator of cytokinesis 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRC1 mRNA
CTD
PMID:32741896
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdm10
PR/SET domain 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRDM10 mRNA
CTD
PMID:32741896
NCBI chr 8:29,724,011...29,827,757
Ensembl chr 8:29,724,245...29,826,080
G
Prf1
perforin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRF1 mRNA
CTD
PMID:32741896
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRG2 mRNA
CTD
PMID:32741896
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PRKAR1A promoter
CTD
PMID:27415467
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Prkg2
protein kinase cGMP-dependent 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PRKG2 promoter
CTD
PMID:27415467
NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888
G
Prl
prolactin
multiple interactions increases secretion
EXP
Atrazine inhibits the reaction [estradiol 3-benzoate results in increased secretion of PRL protein]; estradiol 3-benzoate results in increased expression of and results in increased secretion of PRL protein; Mifepristone promotes the reaction [estradiol 3-benzoate results in increased secretion of PRL protein]
CTD
PMID:2159045 PMID:10696778 PMID:27830003
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prmt8
protein arginine methyltransferase 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PRMT8 mRNA
CTD
PMID:32741896
NCBI chr 4:160,535,813...160,618,193
Ensembl chr 4:160,535,813...160,617,930
G
Prr16
proline rich 16
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRR16 mRNA
CTD
PMID:32741896
NCBI chr18:44,424,348...44,764,796
Ensembl chr18:44,424,616...44,632,329
G
Prr7
proline rich 7 (synaptic)
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRR7 mRNA
CTD
PMID:32741896
NCBI chr17:9,164,375...9,173,669
Ensembl chr17:9,165,269...9,172,536
G
Prrc1
proline-rich coiled-coil 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PRRC1 promoter
CTD
PMID:27415467
NCBI chr18:50,812,548...50,846,273
Ensembl chr18:50,812,552...50,849,476
G
Prrc2a
proline-rich coiled-coil 2A
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PRRC2A promoter
CTD
PMID:27415467
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
G
Prss12
serine protease 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PRSS12 mRNA
CTD
PMID:32741896
NCBI chr 2:211,624,134...211,684,126
Ensembl chr 2:211,624,134...211,684,126
G
Psapl1
prosaposin-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PSAPL1 mRNA
CTD
PMID:32741896
NCBI chr14:74,544,646...74,547,206
Ensembl chr14:74,544,646...74,547,206
G
Psat1
phosphoserine aminotransferase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PSAT1 mRNA
CTD
PMID:32741896
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psma6-ps1
proteasome 20S subunit alpha 6, pseudogene 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of PSMA6-PS1 promoter
CTD
PMID:27415467
NCBI chr20:16,823,684...16,824,632
G
Psmb8
proteasome 20S subunit beta 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PSMB8 mRNA
CTD
PMID:32741896
NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283
G
Pstpip1
proline-serine-threonine phosphatase-interacting protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PSTPIP1 mRNA
CTD
PMID:32741896
NCBI chr 8:56,499,287...56,538,593
Ensembl chr 8:56,499,590...56,538,580
G
Ptafr
platelet-activating factor receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTAFR mRNA
CTD
PMID:32741896
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Ptgdr
prostaglandin D2 receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTGDR mRNA
CTD
PMID:32741896
NCBI chr15:17,360,304...17,367,679
Ensembl chr15:17,360,304...17,367,679
G
Ptger2
prostaglandin E receptor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTGER2 mRNA
CTD
PMID:32741896
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTGS2 mRNA
CTD
PMID:32741896
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PTPN13 mRNA
CTD
PMID:32741896
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPN22 mRNA
CTD
PMID:32741896
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
Ptprc
protein tyrosine phosphatase, receptor type, C
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPRC mRNA
CTD
PMID:32741896
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Ptpre
protein tyrosine phosphatase, receptor type, E
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPRE mRNA
CTD
PMID:32741896
NCBI chr 1:190,344,331...190,494,815
Ensembl chr 1:190,344,401...190,489,534
G
Ptpro
protein tyrosine phosphatase, receptor type, O
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPRO mRNA
CTD
PMID:32741896
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of PTTG1 mRNA; estradiol 3-benzoate results in increased expression of PTTG1 protein [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTTG1 mRNA
CTD
PMID:27830003 PMID:32741896
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Ptx3
pentraxin 3
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of PTX3 promoter
CTD
PMID:27415467
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Pvrig
PVR related immunoglobulin domain containing
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PVRIG mRNA
CTD
PMID:32741896
NCBI chr12:17,363,721...17,365,577
Ensembl chr12:17,364,080...17,365,280
G
Pwwp3b
PWWP domain containing 3B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MUM1L1 mRNA
CTD
PMID:32741896
NCBI chr X:102,804,416...102,838,580
Ensembl chr X:102,804,520...102,838,574
G
Pxdn
peroxidasin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PXDN mRNA
CTD
PMID:32741896
NCBI chr 6:46,580,749...46,658,345
Ensembl chr 6:46,580,761...46,658,345
G
Pym1
PYM homolog 1, exon junction complex associated factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PYM1 mRNA
CTD
PMID:32741896
NCBI chr 7:1,177,746...1,200,899
Ensembl chr 7:1,178,008...1,198,937
G
Qprt
quinolinate phosphoribosyltransferase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of QPRT mRNA
CTD
PMID:32741896
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
G
Rab32
RAB32, member RAS oncogene family
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAB32 mRNA
CTD
PMID:32741896
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rab37
RAB37, member RAS oncogene family
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAB37 mRNA
CTD
PMID:32741896
NCBI chr10:100,334,639...100,401,974
Ensembl chr10:100,334,216...100,401,474
G
Rab42
RAB42, member RAS oncogene family
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAB42 mRNA
CTD
PMID:32741896
NCBI chr 5:144,497,159...144,498,829
Ensembl chr 5:144,496,215...144,498,848
G
Rac2
Rac family small GTPase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAC2 mRNA
CTD
PMID:32741896
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rad54b
RAD54 homolog B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of RAD54B mRNA
CTD
PMID:32741896
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
decreases phosphorylation
EXP
estradiol 3-benzoate results in decreased phosphorylation of RAF1 protein
CTD
PMID:15778002
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Ramp3
receptor activity modifying protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAMP3 mRNA
CTD
PMID:32741896
NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902
G
Rarres1
retinoic acid receptor responder 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RARRES1 mRNA
CTD
PMID:32741896
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
G
Rasa3
RAS p21 protein activator 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RASA3 mRNA
CTD
PMID:32741896
NCBI chr16:75,855,360...75,969,349
Ensembl chr16:75,855,265...75,970,804
G
Rasd1
ras related dexamethasone induced 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RASD1 mRNA
CTD
PMID:32741896
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rasgrp4
RAS guanyl releasing protein 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RASGRP4 mRNA
CTD
PMID:32741896
NCBI chr 1:84,433,033...84,452,841
Ensembl chr 1:84,433,064...84,451,896
G
RatNP-3b
defensin RatNP-3 precursor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RATNP-3B mRNA
CTD
PMID:32741896
NCBI chr16:70,544,364...70,546,533
Ensembl chr16:70,513,888...70,546,522
G
Rbpjl
recombination signal binding protein for immunoglobulin kappa J region-like
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of RBPJL promoter
CTD
PMID:27415467
NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
G
Rcan3
RCAN family member 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of RCAN3 promoter
CTD
PMID:27415467
NCBI chr 5:147,650,935...147,671,881
Ensembl chr 5:147,655,085...147,671,937
G
Reg3g
regenerating family member 3 gamma
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of REG3G mRNA
CTD
PMID:32741896
NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723
G
Relt
RELT, TNF receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA
CTD
PMID:32741896
NCBI chr 1:155,206,976...155,224,609
Ensembl chr 1:155,206,976...155,214,196
G
Rflna
refilin A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RFLNA mRNA
CTD
PMID:32741896
NCBI chr12:31,633,360...31,642,313
Ensembl chr12:31,633,361...31,642,317
G
Rftn1
raftlin lipid raft linker 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RFTN1 mRNA
CTD
PMID:32741896
NCBI chr 9:10,804,611...11,002,084
Ensembl chr 9:10,804,611...11,002,084
G
RGD1559536
similar to vitellogenin-like 1 precursor
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of RGD1559536 mRNA
CTD
PMID:32741896
NCBI chr18:36,488,275...36,491,647
Ensembl chr18:36,488,275...36,491,647
G
RGD1559575
similar to novel protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGD1559575 mRNA
CTD
PMID:32741896
NCBI chr10:33,252,146...33,276,364
Ensembl chr10:33,252,134...33,276,225
G
RGD2301395
similar to killer cell lectin-like receptor subfamily B member 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGD2301395 mRNA
CTD
PMID:32741896
G
Rgs10
regulator of G-protein signaling 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS10 mRNA
CTD
PMID:32741896
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs13
regulator of G-protein signaling 13
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS13 mRNA
CTD
PMID:32741896
NCBI chr13:55,922,290...55,955,753
Ensembl chr13:55,922,395...55,955,648
G
Rgs14
regulator of G-protein signaling 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS14 mRNA
CTD
PMID:32741896
NCBI chr17:9,248,982...9,263,104
Ensembl chr17:9,249,019...9,263,104
G
Rgs18
regulator of G-protein signaling 18
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS18 mRNA
CTD
PMID:32741896
NCBI chr13:56,493,134...56,516,045
Ensembl chr13:56,494,010...56,516,098
G
Rgs20
regulator of G-protein signaling 20
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of RGS20 promoter
CTD
PMID:27415467
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
G
Rhoxl
reproductive homeobox like
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of RHOXL promoter
CTD
PMID:27415467
NCBI chr X:116,442,675...116,444,106
Ensembl chr X:116,441,825...116,444,081
G
Rig1
RNA sensor RIG-1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIGI mRNA
CTD
PMID:32741896
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Ripk3
receptor-interacting serine-threonine kinase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPK3 mRNA
CTD
PMID:32741896
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Ripor2
RHO family interacting cell polarization regulator 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPOR2 mRNA
CTD
PMID:32741896
NCBI chr17:40,323,748...40,547,482
Ensembl chr17:40,323,867...40,548,092
G
Rnase1
ribonuclease A family member 1, pancreatic
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RNASE1 mRNA
CTD
PMID:32741896
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
G
Rnase1l1
ribonuclease, RNase A family, 1-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RNASE1L1 mRNA
CTD
PMID:32741896
NCBI chr15:24,338,216...24,339,934
Ensembl chr15:24,338,479...24,338,931
G
Rnf180
ring finger protein 180
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of RNF180 mRNA
CTD
PMID:32741896
NCBI chr 2:36,330,285...36,511,168
Ensembl chr 2:36,330,292...36,512,614
G
Rnf186
ring finger protein 186
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of RNF186 promoter
CTD
PMID:27415467
NCBI chr 5:151,210,492...151,211,716
Ensembl chr 5:151,210,492...151,211,716
G
Rps4x-ps1
ribosomal protein S4, X-linked, pseudogene 1
increases expression
EXP
estradiol 3-benzoate results in increased expression of RPS4X-PS1 mRNA
CTD
PMID:32741896
NCBI chr 1:231,210,277...231,211,564
G
Rrm2
ribonucleotide reductase regulatory subunit M2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RRM2 mRNA
CTD
PMID:32741896
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rsph1
radial spoke head component 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of RSPH1 promoter
CTD
PMID:27415467
NCBI chr20:9,341,910...9,360,640
Ensembl chr20:9,341,913...9,360,640
G
RT1-Bb
RT1 class II, locus Bb
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-BB mRNA
CTD
PMID:32741896
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-CE10
RT1 class I, locus CE10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-CE10 mRNA
CTD
PMID:32741896
NCBI chr20:3,377,284...3,380,301
G
RT1-CE11
RT1 class I, locus CE11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of RT1-CE11 mRNA
CTD
PMID:32741896
NCBI chr20:3,355,393...3,358,520
Ensembl chr20:3,350,937...3,380,362
G
RT1-CE6
RT1 class I, locus CE6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-CE6 mRNA
CTD
PMID:32741896
NCBI chr20:3,460,979...3,461,929
G
RT1-Da
RT1 class II, locus Da
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-DA mRNA
CTD
PMID:32741896
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
RT1-Db1
RT1 class II, locus Db1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-DB1 mRNA
CTD
PMID:32741896
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Db2
RT1 class II, locus Db2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-DB2 mRNA
CTD
PMID:32741896
NCBI chr20:4,520,723...4,539,724
Ensembl chr20:4,520,713...4,539,705
G
RT1-DOb
RT1 class II, locus DOb
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-DOB mRNA
CTD
PMID:32741896
NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,816...4,625,667
G
RT1-M2
RT1 class Ib, locus M2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-M2 mRNA
CTD
PMID:32741896
NCBI chr20:978,918...981,510
Ensembl chr20:978,935...981,723
G
RT1-N3
RT1 class Ib, locus N3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-N3 mRNA
CTD
PMID:32741896
NCBI chr20:2,659,132...2,665,536
Ensembl chr20:2,661,584...2,665,530
G
RT1-T24-1
RT1 class I, locus T24, gene 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-T24-1 mRNA
CTD
PMID:32741896
NCBI chr20:2,761,495...2,774,871
Ensembl chr20:2,718,279...2,776,154
G
RT1-T24-3
RT1 class I, locus T24, gene 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RT1-T24-3 mRNA
CTD
PMID:32741896
NCBI chr20:2,718,210...2,730,604
Ensembl chr20:2,718,279...2,776,154
G
Rtp3
receptor (chemosensory) transporter protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RTP3 mRNA
CTD
PMID:32741896
NCBI chr 8:110,970,154...110,975,000
Ensembl chr 8:110,970,160...110,974,699
G
Runx1
RUNX family transcription factor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RUNX1 mRNA
CTD
PMID:32741896
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Runx3
RUNX family transcription factor 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of RUNX3 promoter
CTD
PMID:27415467
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
G
Rwdd2a
RWD domain containing 2A
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of RWDD2A mRNA
CTD
PMID:32741896
NCBI chr 8:87,536,153...87,539,301
Ensembl chr 8:87,536,176...87,539,300
G
Rxfp1
relaxin family peptide receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA
CTD
PMID:32741896
NCBI chr 2:164,772,270...164,893,484
Ensembl chr 2:164,774,799...164,893,412
G
Rxrg
retinoid X receptor gamma
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXRG mRNA
CTD
PMID:32741896
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
S100a14
S100 calcium binding protein A14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A14 mRNA
CTD
PMID:32741896
NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:176,008,395...176,010,423
G
S100a4
S100 calcium-binding protein A4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A4 mRNA
CTD
PMID:32741896
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100a8
S100 calcium binding protein A8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A8 mRNA
CTD
PMID:32741896
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A9 mRNA
CTD
PMID:32741896
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Samd9
sterile alpha motif domain containing 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SAMD9 mRNA
CTD
PMID:32741896
NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SAMSN1 mRNA
CTD
PMID:32741896
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
G
Sapcd2
suppressor APC domain containing 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SAPCD2 mRNA
CTD
PMID:32741896
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Scara3
scavenger receptor class A, member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCARA3 mRNA
CTD
PMID:32741896
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
G
Scart1
scavenger receptor family member expressed on T-cells 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCART1 mRNA
CTD
PMID:32741896
NCBI chr 1:195,020,750...195,031,807
Ensembl chr 1:195,020,750...195,031,807
G
Scel
sciellin
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of SCEL promoter
CTD
PMID:27415467
NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372
G
Scgb1a1
secretoglobin family 1A member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCGB1A1 mRNA
CTD
PMID:32741896
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
G
Scimp
SLP adaptor and CSK interacting membrane protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCIMP mRNA
CTD
PMID:32741896
NCBI chr10:55,507,646...55,527,764
Ensembl chr10:55,507,519...55,528,171
G
Scpep1
serine carboxypeptidase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCPEP1 mRNA
CTD
PMID:32741896
NCBI chr10:73,703,275...73,732,892
Ensembl chr10:73,703,278...73,732,850
G
Sct
secretin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCT mRNA
CTD
PMID:32741896
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
G
Sctr
secretin receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCTR mRNA
CTD
PMID:32741896
NCBI chr13:31,127,781...31,190,162
Ensembl chr13:31,127,858...31,180,189
G
Sec14l2
SEC14-like lipid binding 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of SEC14L2 promoter
CTD
PMID:27415467
NCBI chr14:78,973,805...78,998,480
Ensembl chr14:78,973,808...78,993,788
G
Sele
selectin E
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SELE mRNA
CTD
PMID:32741896
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selenop
selenoprotein P
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SELENOP mRNA
CTD
PMID:32741896
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sell
selectin L
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SELL mRNA
CTD
PMID:32741896
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Selplg
selectin P ligand
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SELPLG mRNA
CTD
PMID:32741896
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
G
Sema4f
ssemaphorin 4F
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SEMA4F mRNA
CTD
PMID:32741896
NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721
G
Sema6b
semaphorin 6B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SEMA6B mRNA
CTD
PMID:32741896
NCBI chr 9:950,939...967,905
Ensembl chr 9:950,939...961,521
G
Septin1
septin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SEPTIN1 mRNA
CTD
PMID:32741896
NCBI chr 1:181,832,700...181,836,566
Ensembl chr 1:181,832,701...181,836,566
G
Septin6
septin 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SEPTIN6 mRNA
CTD
PMID:32741896
NCBI chr X:116,153,255...116,230,334
Ensembl chr X:116,153,255...116,230,115
G
Serpina1f
serpin family A member 1F
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SERPINA1F mRNA
CTD
PMID:32741896
NCBI chr 6:122,820,752...122,827,112
Ensembl chr 6:122,820,907...122,827,112
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SERPINA3N mRNA
CTD
PMID:32741896
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serping1
serpin family G member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SERPING1 mRNA
CTD
PMID:32741896
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sfrp4
secreted frizzled-related protein 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SFRP4 mRNA
CTD
PMID:32741896
NCBI chr17:45,278,867...45,330,806
Ensembl chr17:45,234,097...45,330,736
G
Sft2d2
SFT2 domain containing 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SFT2D2 mRNA
CTD
PMID:32741896
NCBI chr13:77,484,778...77,504,123
Ensembl chr13:77,484,636...77,504,112
G
Sgo1
shugoshin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SGO1 mRNA
CTD
PMID:32741896
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805
G
Sgo2
shugoshin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SGO2 mRNA
CTD
PMID:32741896
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
G
Sh2d1a
SH2 domain containing 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SH2D1A mRNA
CTD
PMID:32741896
NCBI chr X:121,373,693...121,401,923
G
Sh2d2a
SH2 domain containing 2A
increases expression
EXP
estradiol 3-benzoate results in increased expression of SH2D2A mRNA
CTD
PMID:32741896
NCBI chr 2:173,312,253...173,318,810
Ensembl chr 2:173,312,253...173,318,810
G
Sh2d3c
SH2 domain containing 3C
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SH2D3C mRNA
CTD
PMID:32741896
NCBI chr 3:16,010,622...16,046,491
Ensembl chr 3:16,010,625...16,046,484
G
Sh3bp1
SH3-domain binding protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SH3BP1 mRNA
CTD
PMID:32741896
NCBI chr 7:110,457,626...110,470,201
Ensembl chr 7:110,457,710...110,470,201
G
Shank3
SH3 and multiple ankyrin repeat domains 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SHANK3 mRNA
CTD
PMID:32741896
NCBI chr 7:120,568,707...120,630,796
Ensembl chr 7:120,570,402...120,630,374
G
Shcbp1
SHC binding and spindle associated 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SHCBP1 mRNA
CTD
PMID:32741896
NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844
G
Shroom1
shroom family member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SHROOM1 mRNA
CTD
PMID:32741896
NCBI chr10:37,621,149...37,631,895
Ensembl chr10:37,621,723...37,631,256
G
Siglec1
sialic acid binding Ig like lectin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SIGLEC1 mRNA
CTD
PMID:32741896
NCBI chr 3:118,287,988...118,307,125
Ensembl chr 3:118,287,988...118,306,850
G
Sirt4
sirtuin 4
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of SIRT4 promoter
CTD
PMID:27415467
NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439
G
Sit1
signaling threshold regulating transmembrane adaptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SIT1 mRNA
CTD
PMID:32741896
NCBI chr 5:57,740,212...57,741,838
Ensembl chr 5:57,740,218...57,741,838
G
Sla
src-like adaptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLA mRNA
CTD
PMID:32741896
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Sla2
Src-like-adaptor 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLA2 mRNA
CTD
PMID:32741896
NCBI chr 3:145,367,070...145,383,586
Ensembl chr 3:145,368,598...145,382,480
G
Slamf7
SLAM family member 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF7 mRNA
CTD
PMID:32741896
NCBI chr13:84,135,656...84,154,528
Ensembl chr13:84,136,899...84,154,105
G
Slamf8
SLAM family member 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF8 mRNA
CTD
PMID:32741896
NCBI chr13:85,047,729...85,057,571
Ensembl chr13:85,047,727...85,057,211
G
Slamf9
SLAM family member 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF9 mRNA
CTD
PMID:32741896
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:84,941,982...84,944,748
G
Slc11a1
solute carrier family 11 member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC11A1 mRNA
CTD
PMID:32741896
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc13a2
solute carrier family 13 member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC13A2 mRNA
CTD
PMID:32741896
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
G
Slc13a3
solute carrier family 13 member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC13A3 mRNA
CTD
PMID:32741896
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc15a3
solute carrier family 15 member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC15A3 mRNA
CTD
PMID:32741896
NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157
G
Slc16a1
solute carrier family 16 member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC16A1 mRNA
CTD
PMID:32741896
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a7
solute carrier family 16 member 7
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of SLC16A7 promoter
CTD
PMID:27415467
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
G
Slc26a1
solute carrier family 26 member 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of SLC26A1 promoter
CTD
PMID:27415467
NCBI chr14:1,040,565...1,045,851
Ensembl chr14:1,040,243...1,045,849
G
Slc26a10
solute carrier family 26, member 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC26A10 mRNA
CTD
PMID:32741896
NCBI chr 7:62,995,165...63,005,099
Ensembl chr 7:62,995,381...63,004,087
G
Slc28a2
solute carrier family 28 member 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC28A2 mRNA
CTD
PMID:32741896
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc2a3
solute carrier family 2 member 3
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of SLC2A3 promoter
CTD
PMID:27415467
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc2a6
solute carrier family 2 member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA
CTD
PMID:32741896
NCBI chr 3:10,348,395...10,355,208
Ensembl chr 3:10,348,395...10,355,208
G
Slc31a1
solute carrier family 31 member 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SLC31A1 mRNA
CTD
PMID:32741896
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc37a2
solute carrier family 37 member 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SLC37A2 mRNA
CTD
PMID:32741896
NCBI chr 8:36,945,787...36,971,748
Ensembl chr 8:36,946,930...36,971,482
G
Slc38a11
solute carrier family 38, member 11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SLC38A11 mRNA
CTD
PMID:32741896
NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
G
Slc38a5
solute carrier family 38, member 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC38A5 mRNA
CTD
PMID:32741896
NCBI chr X:14,213,727...14,222,498
Ensembl chr X:14,213,729...14,222,498
G
Slc39a10
solute carrier family 39 member 10
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of SLC39A10 mRNA [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SLC39A10 mRNA
CTD
PMID:32741896
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
G
Slc39a2
solute carrier family 39 member 2
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SLC39A2 mRNA
CTD
PMID:32741896
NCBI chr15:24,590,738...24,592,850
Ensembl chr15:24,590,738...24,592,850
G
Slc39a8
solute carrier family 39 member 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC39A8 mRNA
CTD
PMID:32741896
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Slc47a1
solute carrier family 47 member 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC47A1 mRNA
CTD
PMID:32741896
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
G
Slc4a4
solute carrier family 4 member 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC4A4 mRNA
CTD
PMID:32741896
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc6a1
solute carrier family 6 member 1
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SLC6A1 mRNA
CTD
PMID:15664431
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Slc6a12
solute carrier family 6 member 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A12 mRNA
CTD
PMID:32741896
NCBI chr 4:154,585,386...154,603,750
Ensembl chr 4:154,585,500...154,603,750
G
Slc6a14
solute carrier family 6 member 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A14 mRNA
CTD
PMID:32741896
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Slc6a3
solute carrier family 6 member 3
multiple interactions
ISO
estradiol 3-benzoate inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 mRNA]; estradiol 3-benzoate inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]
CTD
PMID:15249736
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of SLC6A4 protein Raloxifene Hydrochloride inhibits the reaction [estradiol 3-benzoate results in increased expression of SLC6A4 protein]
CTD
PMID:17398000
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slc6a6
solute carrier family 6 member 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA
CTD
PMID:32741896
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
G
Slc7a3
solute carrier family 7 member 3
increases expression
EXP
estradiol 3-benzoate results in increased expression of SLC7A3 mRNA
CTD
PMID:32741896
NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708
G
Slc7a5
solute carrier family 7 member 5
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SLC7A5 mRNA
CTD
PMID:32741896
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc7a7
solute carrier family 7 member 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC7A7 mRNA
CTD
PMID:32741896
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Slc8a1
solute carrier family 8 member A1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of SLC8A1 promoter
CTD
PMID:27415467
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slfn4
schlafen family member 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLFN4 mRNA
CTD
PMID:32741896
NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138 Ensembl chr10:68,000,028...68,018,138
G
Slit1
slit guidance ligand 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLIT1 mRNA
CTD
PMID:32741896
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
G
Slitrk5
SLIT and NTRK-like family, member 5
increases expression
EXP
estradiol 3-benzoate results in increased expression of SLITRK5 mRNA
CTD
PMID:32741896
NCBI chr15:88,848,123...88,858,809
Ensembl chr15:88,847,535...88,856,836
G
Slpi-ps1
secretory leukocyte peptidase inhibitor, pseudogene 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLPI-PS1 mRNA
CTD
PMID:32741896
NCBI chr 3:153,019,109...153,021,371
Ensembl chr 3:153,019,109...153,021,360 Ensembl chr 3:153,019,109...153,021,360
G
Smim5
small integral membrane protein 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SMIM5 mRNA
CTD
PMID:32741896
NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SMPDL3A mRNA
CTD
PMID:32741896
NCBI chr20:37,132,592...37,155,567
Ensembl chr20:37,132,592...37,155,567
G
Sntg1
syntrophin, gamma 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SNTG1 mRNA
CTD
PMID:32741896
NCBI chr 5:9,980,550...10,794,666
Ensembl chr 5:9,981,115...10,791,181
G
Snx10
sorting nexin 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA
CTD
PMID:32741896
NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
G
Snx31
sorting nexin 31
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SNX31 mRNA
CTD
PMID:32741896
NCBI chr 7:67,676,514...67,776,925
Ensembl chr 7:67,676,524...67,732,086
G
Socs3
suppressor of cytokine signaling 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SOCS3 mRNA
CTD
PMID:32741896
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod1
superoxide dismutase 1
decreases expression multiple interactions
EXP
estradiol 3-benzoate results in decreased expression of SOD1 mRNA; estradiol 3-benzoate results in decreased expression of SOD1 protein Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased expression of SOD1 mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in decreased expression of SOD1 protein]
CTD
PMID:24316378
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sox18
SRY-box transcription factor 18
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SOX18 mRNA
CTD
PMID:32741896
NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290
G
Sox2
SRY-box transcription factor 2
decreases methylation increases expression
EXP
estradiol 3-benzoate results in decreased methylation of SOX2 promoter estradiol 3-benzoate results in increased expression of SOX2 mRNA
CTD
PMID:27415467
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Spag11b
sperm associated antigen 11B
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SPAG11A mRNA
CTD
PMID:32741896
NCBI chr16:70,697,810...70,700,336
Ensembl chr16:70,698,127...70,700,110
G
Spag5
sperm associated antigen 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPAG5 mRNA
CTD
PMID:32741896
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Sphkap
SPHK1 interactor, AKAP domain containing
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPHKAP mRNA
CTD
PMID:32741896
NCBI chr 9:84,509,383...84,657,582
Ensembl chr 9:84,510,964...84,657,559
G
Spi1
Spi-1 proto-oncogene
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPI1 mRNA
CTD
PMID:32741896
NCBI chr 3:77,059,744...77,093,730
Ensembl chr 3:77,073,012...77,092,393
G
Spib
Spi-B transcription factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPIB mRNA
CTD
PMID:32741896
NCBI chr 1:95,018,939...95,024,804
Ensembl chr 1:95,018,947...95,024,780
G
Spink5
serine peptidase inhibitor, Kazal type 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPINK5 mRNA
CTD
PMID:32741896
NCBI chr18:36,264,452...36,333,143
Ensembl chr18:36,264,452...36,332,185
G
Spmap2l
sperm microtubule associated protein 2 like
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of SPMAP2L promoter
CTD
PMID:27415467
NCBI chr14:31,110,104...31,152,487
Ensembl chr14:31,110,106...31,151,561
G
Spon1
spondin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPON1 mRNA
CTD
PMID:32741896
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spp1
secreted phosphoprotein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPP1 mRNA
CTD
PMID:32741896
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sprr1a
small proline-rich protein 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPRR1A mRNA
CTD
PMID:32741896
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Sprr2d
small proline-rich protein 2D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SPRR2D mRNA
CTD
PMID:32741896
NCBI chr 2:177,870,082...177,870,679
Ensembl chr 2:177,870,434...177,870,679
G
Sptb
spectrin, beta, erythrocytic
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPTB mRNA
CTD
PMID:32741896
NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of SPTLC3 mRNA
CTD
PMID:32741896
NCBI chr 3:126,847,878...126,978,010
Ensembl chr 3:126,847,878...126,978,010
G
Srgn
serglycin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRGN mRNA
CTD
PMID:32741896
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Srms
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRMS mRNA
CTD
PMID:32741896
NCBI chr 3:168,318,511...168,324,915
Ensembl chr 3:168,318,512...168,324,915
G
Srpk3
SRSF protein kinase 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRPK3 mRNA
CTD
PMID:32741896
NCBI chr X:151,510,452...151,515,208
Ensembl chr X:151,510,539...151,515,198
G
Srxn1
sulfiredoxin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRXN1 mRNA
CTD
PMID:32741896
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
St18
ST18 C2H2C-type zinc finger transcription factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ST18 mRNA
CTD
PMID:32741896
NCBI chr 5:12,582,493...12,914,221
Ensembl chr 5:12,584,110...12,671,790
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ST3GAL1 mRNA
CTD
PMID:32741896
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St8sia4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ST8SIA4 mRNA
CTD
PMID:32741896
NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:95,993,503...96,084,653
G
Stab1
stabilin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STAB1 mRNA
CTD
PMID:32741896
NCBI chr16:6,330,435...6,360,934
Ensembl chr16:6,330,444...6,360,923
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STAT1 mRNA
CTD
PMID:32741896
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat5b
signal transducer and activator of transcription 5B
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of STAT5B promoter
CTD
PMID:27415467
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
G
Steap4
STEAP4 metalloreductase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STEAP4 mRNA
CTD
PMID:32741896
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
G
Stfa2l2
stefin A2-like 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STFA2L2 mRNA
CTD
PMID:32741896
NCBI chr11:64,498,151...64,500,576
Ensembl chr11:64,498,206...64,500,574
G
Stk10
serine/threonine kinase 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STK10 mRNA
CTD
PMID:32741896
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
G
Stk16
serine/threonine kinase 16
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of STK16 promoter
CTD
PMID:27415467
NCBI chr 9:76,705,591...76,708,859
Ensembl chr 9:76,705,602...76,708,855
G
Stmn2
stathmin 2
increases expression
EXP
estradiol 3-benzoate results in increased expression of STMN2 mRNA
CTD
PMID:32741896
NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011
G
Ston1
stonin 1
multiple interactions increases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of STON1 mRNA estradiol 3-benzoate results in increased expression of RAET1L mRNA
CTD
PMID:32741896
NCBI chr 6:5,843,186...5,892,557
Ensembl chr 6:5,843,185...5,892,449
G
Strip2
striatin interacting protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STRIP2 mRNA
CTD
PMID:32741896
NCBI chr 4:58,536,034...58,578,279
Ensembl chr 4:58,536,055...58,578,291
G
Stx11
syntaxin 11
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA
CTD
PMID:32741896
NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164
G
Styk1
serine/threonine/tyrosine kinase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STYK1 mRNA
CTD
PMID:32741896
NCBI chr 4:165,047,613...165,097,890
Ensembl chr 4:165,048,440...165,096,440
G
Sulf2
sulfatase 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA
CTD
PMID:32741896
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
G
Syt7
synaptotagmin 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SYT7 mRNA
CTD
PMID:32741896
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
G
Syt8
synaptotagmin 8
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SYT8 mRNA
CTD
PMID:32741896
NCBI chr 1:197,588,126...197,593,598
Ensembl chr 1:197,590,149...197,593,504
G
Tac4
tachykinin precursor 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TAC4 mRNA
CTD
PMID:32741896
NCBI chr10:80,207,824...80,216,156
Ensembl chr10:80,207,610...80,216,156
G
Tacc3
transforming, acidic coiled-coil containing protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA
CTD
PMID:32741896
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
G
Tacr1
tachykinin receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACR1 mRNA
CTD
PMID:32741896
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
G
Tacstd2
tumor-associated calcium signal transducer 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of TACSTD2 promoter
CTD
PMID:27415467
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
G
Tap1
transporter 1, ATP binding cassette subfamily B member
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TAP1 mRNA
CTD
PMID:32741896
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tarbp2
Tarbp2 subunit of RISC loading complex
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of TARBP2 promoter
CTD
PMID:27415467
NCBI chr 7:133,649,118...133,654,306
Ensembl chr 7:133,649,090...133,654,314
G
Tat
tyrosine aminotransferase
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of TAT promoter
CTD
PMID:27415467
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d8b
TBC1 domain family member 8B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TBC1D8B mRNA
CTD
PMID:32741896
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbx4
T-box transcription factor 4
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of TBX4 promoter
CTD
PMID:27415467
NCBI chr10:70,730,686...70,760,829
Ensembl chr10:70,731,163...70,760,825
G
Tbxas1
thromboxane A synthase 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TBXAS1 mRNA
CTD
PMID:32741896
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
G
Tf
transferrin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TF mRNA
CTD
PMID:32741896
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb2
transforming growth factor, beta 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TGFB2 mRNA
CTD
PMID:32741896
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tgfbi
transforming growth factor, beta induced
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TGFBI mRNA
CTD
PMID:32741896
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
G
Thbs2
thrombospondin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of THBS2 mRNA
CTD
PMID:32741896
NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
G
Them5
thioesterase superfamily member 5
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of THEM5 mRNA
CTD
PMID:32741896
NCBI chr 2:181,980,783...181,986,002
Ensembl chr 2:181,980,783...181,986,002
G
Ticam2
TIR domain containing adaptor molecule 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TICAM2 mRNA
CTD
PMID:32741896
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TICRR mRNA
CTD
PMID:32741896
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Tifab
TIFA inhibitor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TIFAB mRNA
CTD
PMID:32741896
NCBI chr17:8,433,406...8,436,541
Ensembl chr17:8,431,635...8,436,592
G
Timd4
T-cell immunoglobulin and mucin domain containing 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TIMD4 mRNA
CTD
PMID:32741896
NCBI chr10:31,185,751...31,221,843
Ensembl chr10:31,185,731...31,220,966
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TIMP1 mRNA
CTD
PMID:32741896
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tle6
TLE family member 6, subcortical maternal complex member
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TLE6 mRNA
CTD
PMID:32741896
NCBI chr 7:8,107,050...8,118,639
Ensembl chr 7:8,107,207...8,118,639
G
Tln2
talin 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TLN2 mRNA
CTD
PMID:32741896
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tlr1
toll-like receptor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TLR1 mRNA
CTD
PMID:32741896
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr10
toll-like receptor 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TLR10 mRNA
CTD
PMID:32741896
NCBI chr14:43,400,843...43,414,056
Ensembl chr14:43,406,217...43,413,917
G
Tlr7
toll-like receptor 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TLR7 mRNA
CTD
PMID:32741896
NCBI chr X:27,027,380...27,054,309
Ensembl chr X:27,027,425...27,054,754
G
Tmc3
transmembrane channel-like 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TMC3 mRNA
CTD
PMID:32741896
NCBI chr 1:137,552,347...137,597,477
Ensembl chr 1:137,552,455...137,597,633
G
Tmem156
transmembrane protein 156
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM156 mRNA
CTD
PMID:32741896
NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,223,381...43,252,449
G
Tmem176a
transmembrane protein 176A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM176A mRNA
CTD
PMID:32741896
NCBI chr 4:77,774,940...77,778,620
Ensembl chr 4:77,774,843...77,778,620
G
Tmem176b
transmembrane protein 176B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM176B mRNA
CTD
PMID:32741896
NCBI chr 4:77,766,928...77,774,740
Ensembl chr 4:77,766,928...77,774,384
G
Tmem196
transmembrane protein 196
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM196 mRNA
CTD
PMID:32741896
NCBI chr 6:140,895,556...140,959,501
Ensembl chr 6:140,896,576...140,957,435
G
Tmem235
transmembrane protein 235
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM235 mRNA
CTD
PMID:32741896
NCBI chr10:103,081,716...103,092,187
Ensembl chr10:103,086,497...103,092,184
G
Tmem40
transmembrane protein 40
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM40 mRNA
CTD
PMID:32741896
NCBI chr 4:148,791,509...148,819,287
Ensembl chr 4:148,791,505...148,823,665
G
Tmem63c
transmembrane protein 63c
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TMEM63C mRNA
CTD
PMID:32741896
NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:106,672,934...106,736,990
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNF mRNA
CTD
PMID:32741896
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip2
TNF alpha induced protein 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFAIP2 mRNA
CTD
PMID:32741896
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tnfaip8l3
TNF alpha induced protein 8 like 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFAIP8L3 mRNA
CTD
PMID:32741896
NCBI chr 8:54,413,503...54,455,512
Ensembl chr 8:54,414,457...54,500,079
G
Tnfrsf14
TNF receptor superfamily member 14
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFRSF14 mRNA
CTD
PMID:32741896
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfrsf18
TNF receptor superfamily member 18
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFRSF18 mRNA
CTD
PMID:32741896
NCBI chr 5:166,618,461...166,622,353
Ensembl chr 5:166,618,969...166,622,353
G
Tnfrsf1b
TNF receptor superfamily member 1B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFRSF1B mRNA
CTD
PMID:32741896
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf13b
TNF superfamily member 13b
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFSF13B mRNA
CTD
PMID:32741896
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
G
Tnfsf9
TNF superfamily member 9
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFSF9 mRNA
CTD
PMID:32741896
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tnip3
TNFAIP3 interacting protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNIP3 mRNA
CTD
PMID:32741896
NCBI chr 4:94,867,258...94,908,780
Ensembl chr 4:94,811,097...94,907,605
G
Tnpo3
transportin 3
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of TNPO3 promoter
CTD
PMID:27415467
NCBI chr 4:58,142,954...58,220,365
Ensembl chr 4:58,143,001...58,220,433
G
Tob1
transducer of ErbB-2.1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of TOB1 promoter
CTD
PMID:27415467
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Top2a
DNA topoisomerase II alpha
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TOP2A mRNA
CTD
PMID:32741896
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
increases expression multiple interactions
EXP
estradiol 3-benzoate results in increased expression of TP53 mRNA; estradiol 3-benzoate results in increased expression of TP53 protein Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of TP53 mRNA]; Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of TP53 protein]
CTD
PMID:24316378
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpd52
tumor protein D52
increases methylation decreases expression
EXP
estradiol 3-benzoate results in increased methylation of TPD52 promoter estradiol 3-benzoate results in decreased expression of TPD52 mRNA
CTD
PMID:27415467
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
G
Tprg1
tumor protein p63 regulated 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TPRG1 mRNA
CTD
PMID:32741896
NCBI chr11:75,322,470...75,449,907
Ensembl chr11:75,322,470...75,449,907
G
Traf3ip3
TRAF3 interacting protein 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRAF3IP3 mRNA
CTD
PMID:32741896
NCBI chr13:104,694,802...104,719,655
Ensembl chr13:104,694,805...104,719,673
G
Treml4
triggering receptor expressed on myeloid cells-like 4
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TREML4 mRNA
CTD
PMID:32741896
NCBI chr 9:12,718,968...12,743,879
Ensembl chr 9:12,721,815...12,743,253
G
Trim15
tripartite motif containing 15
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRIM15 mRNA
CTD
PMID:32741896
NCBI chr20:1,700,905...1,710,249
Ensembl chr20:1,700,905...1,710,249
G
Trim2
tripartite motif-containing 2
decreases methylation
EXP
estradiol 3-benzoate results in decreased methylation of TRIM2 promoter
CTD
PMID:27415467
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim6
tripartite motif containing 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRIM6 mRNA
CTD
PMID:32741896
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914
G
Trim63
tripartite motif containing 63
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TRIM63 mRNA
CTD
PMID:32741896
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
G
Troap
trophinin associated protein
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TROAP mRNA
CTD
PMID:32741896
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TRPC3 mRNA
CTD
PMID:32741896
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
G
Tshb
thyroid stimulating hormone subunit beta
increases expression
EXP
estradiol 3-benzoate results in increased expression of TSHB protein
CTD
PMID:16570238
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Tspan32
tetraspanin 32
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TSPAN32 mRNA
CTD
PMID:32741896
NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:198,190,164...198,204,445
G
Ttll6
tubulin tyrosine ligase like 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TTLL6 mRNA
CTD
PMID:32741896
NCBI chr10:81,081,985...81,118,009
Ensembl chr10:81,091,975...81,127,234
G
Tub
TUB bipartite transcription factor
increases expression
EXP
estradiol 3-benzoate results in increased expression of TUB mRNA
CTD
PMID:32741896
NCBI chr 1:163,008,198...163,030,958
Ensembl chr 1:162,951,931...163,026,812
G
Tuba8
tubulin, alpha 8
multiple interactions decreases expression
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of TUBA8 mRNA estradiol 3-benzoate results in decreased expression of TUBA8 mRNA
CTD
PMID:32741896
NCBI chr 4:154,440,045...154,456,918
Ensembl chr 4:154,440,074...154,456,917
G
Tubb2b
tubulin, beta 2B class IIb
decreases methylation multiple interactions
EXP
estradiol 3-benzoate results in decreased methylation of TUBB2B promoter [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TUBB2B mRNA
CTD
PMID:27415467 PMID:32741896
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Tube1
tubulin, epsilon 1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of TUBE1 promoter
CTD
PMID:27415467
NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314
G
Tymp
thymidine phosphorylase
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of TYMP promoter
CTD
PMID:27415467
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Tyrobp
transmembrane immune signaling adaptor Tyrobp
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA
CTD
PMID:32741896
NCBI chr 1:85,672,931...85,676,856
Ensembl chr 1:85,672,994...85,676,848
G
Uba7
ubiquitin-like modifier activating enzyme 7
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBA7 mRNA
CTD
PMID:32741896
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ubash3b
ubiquitin associated and SH3 domain containing, B
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBASH3B mRNA
CTD
PMID:32741896
NCBI chr 8:41,385,419...41,532,248
Ensembl chr 8:41,388,341...41,532,201
G
Ubd
ubiquitin D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBD mRNA
CTD
PMID:32741896
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ube2c
ubiquitin-conjugating enzyme E2C
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA
CTD
PMID:32741896
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2L6 mRNA
CTD
PMID:32741896
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of UGT1A1 promoter
CTD
PMID:27415467
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UGT1A6 mRNA
CTD
PMID:32741896
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2a1
UDP glucuronosyltransferase family 2 member A1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of UGT2A1 mRNA
CTD
PMID:32741896
NCBI chr14:20,521,018...20,545,934
Ensembl chr14:20,517,951...20,545,531
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of UGT2B10 mRNA
CTD
PMID:32741896
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b34l1
UDP glucuronosyltransferase 2 family, polypeptide B34 like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of UGT2B34L1 mRNA
CTD
PMID:32741896
NCBI chr14:21,146,140...21,167,706
Ensembl chr14:21,145,827...21,167,704
G
Unc5cl
unc-5 family C-terminal like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UNC5CL mRNA
CTD
PMID:32741896
NCBI chr 9:12,528,109...12,543,382
Ensembl chr 9:12,528,246...12,542,233
G
Upk1a
uroplakin 1A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of UPK1A mRNA
CTD
PMID:32741896
NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354
G
Usp18
ubiquitin specific peptidase 18
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of USP18 mRNA
CTD
PMID:32741896
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Uts2
urotensin 2
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of UTS2 promoter
CTD
PMID:27415467
NCBI chr 5:161,450,846...161,456,235
Ensembl chr 5:161,450,846...161,456,237
G
Vash1
vasohibin 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VASH1 mRNA
CTD
PMID:32741896
NCBI chr 6:106,330,374...106,345,740
Ensembl chr 6:106,329,123...106,345,726
G
Vav1
vav guanine nucleotide exchange factor 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VAV1 mRNA
CTD
PMID:32741896
NCBI chr 9:2,161,985...2,209,951
Ensembl chr 9:2,157,900...2,208,937
G
Vav3
vav guanine nucleotide exchange factor 3
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VAV3 mRNA
CTD
PMID:32741896
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VCAM1 mRNA
CTD
PMID:32741896
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VCAN mRNA
CTD
PMID:32741896
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vegfd
vascular endothelial growth factor D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VEGFD mRNA
CTD
PMID:32741896
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
G
Vldlr
very low density lipoprotein receptor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VLDLR mRNA
CTD
PMID:32741896
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vof16
ischemia related factor vof-16
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VOF16 mRNA
CTD
PMID:32741896
NCBI chr 8:41,953,062...41,955,169
G
Vsnl1
visinin-like 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VSNL1 mRNA
CTD
PMID:32741896
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Vstm2l
V-set and transmembrane domain containing 2 like
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA
CTD
PMID:32741896
NCBI chr 3:146,571,099...146,600,930
Ensembl chr 3:146,571,278...146,600,325
G
Vtn
vitronectin
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VTN mRNA
CTD
PMID:32741896
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
G
Was
WASP actin nucleation promoting factor
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of WAS mRNA
CTD
PMID:32741896
NCBI chr X:14,405,105...14,413,850
Ensembl chr X:14,405,124...14,413,849
G
Wiz
WIZ zinc finger
increases methylation
EXP
estradiol 3-benzoate results in increased methylation of WIZ promoter
CTD
PMID:27415467
NCBI chr 7:11,366,837...11,395,279
Ensembl chr 7:11,367,035...11,395,490
G
Wnt10b
Wnt family member 10B
increases expression decreases methylation
EXP
estradiol 3-benzoate results in increased expression of WNT10B mRNA estradiol 3-benzoate results in decreased methylation of WNT10B promoter
CTD
PMID:27415467
NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892
G
Xcl1
X-C motif chemokine ligand 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of XCL1 mRNA
CTD
PMID:32741896
NCBI chr13:77,248,687...77,252,343
Ensembl chr13:77,248,717...77,252,329
G
Xdh
xanthine dehydrogenase
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of XDH mRNA
CTD
PMID:32741896
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZAP70 mRNA
CTD
PMID:32741896
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
G
Zbp1
Z-DNA binding protein 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZBP1 mRNA
CTD
PMID:32741896
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
G
Zbtb40
zinc finger and BTB domain containing 40
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZBTB40 mRNA
CTD
PMID:32741896
NCBI chr 5:149,216,496...149,283,746
Ensembl chr 5:149,219,677...149,254,415
G
Zc3h12a
zinc finger CCCH type containing 12A
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZC3H12A mRNA
CTD
PMID:32741896
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zc3h12d
zinc finger CCCH type containing 12D
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZC3H12D mRNA
CTD
PMID:32741896
NCBI chr 1:2,313,110...2,348,820
Ensembl chr 1:2,314,324...2,348,819
G
Zcchc12
zinc finger CCHC-type containing 12
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of ZCCHC12 mRNA
CTD
PMID:32741896
NCBI chr X:115,433,444...115,436,691
Ensembl chr X:115,433,259...115,436,692
G
Zeb2
zinc finger E-box binding homeobox 2
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZEB2 mRNA
CTD
PMID:32741896
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
G
Zeb2-as1
ZEB2 antisense RNA 1
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZEB2OS mRNA
CTD
PMID:32741896
NCBI chr 3:29,343,078...29,345,943
G
Zfp42
zinc finger protein 42
decreases expression
EXP
estradiol 3-benzoate results in decreased expression of ZFP42 mRNA
CTD
PMID:32741896
NCBI chr16:48,836,463...48,845,443
Ensembl chr16:48,836,648...48,845,401
G
Zfp57
zinc finger protein 57
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA
CTD
PMID:32741896
NCBI chr20:1,521,323...1,534,884
Ensembl chr20:1,521,323...1,529,846
G
Zmynd12
zinc finger, MYND-type containing 12
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ZMYND12 mRNA
CTD
PMID:32741896
NCBI chr 5:133,026,917...133,059,985
Ensembl chr 5:133,027,009...133,059,995
G
Zscan10
zinc finger and SCAN domain containing 10
multiple interactions
EXP
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZSCAN10 mRNA
CTD
PMID:32741896
NCBI chr10:12,636,302...12,646,275
Ensembl chr10:12,636,302...12,646,275
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all